Home
  >  
Section 40

EurekaMag Full Text Articles Chapter 39,096



References:

Chen, Y. 1992: A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor. Chinese Journal of Biotechnology 8(3): 179-186
Lyon, R.C.; Faustino, P.J.; Cohen, J.S. 1986: A perfusion technique for 13C NMR studies of the metabolism of 13C-labeled substrates by mammalian cells. Magnetic Resonance in Medicine 3(5): 663-672
Laithier, P.; Bonnin, J.J.; Vannesson, H. 1989: A periapical lesion does not condemn the tooth. Revue Francaise d'Endodontie: Publication Officielle de la Societe Francaise d'Endodontie 8(1): 29-39
Kriz, W. 1987: A periarterial pathway for intrarenal distribution of renin. Kidney International. Suppl 20: S51-S56
Albert, A.P.; Holdsworth, J.; Massyn, C. 1986: A pericentric inversion duplication of the subcentromeric region of chromosome 12q. Journal of Medical Genetics 23(4): 371
Fällström, S.P.; Wahlström, J. 1979: A pericentric inversion of chromosome 9 and a rearrangement involving chromosomes 9 and 10, observed in two generations. Clinical description of chromosome 9 (p12-p21) deletion syndrome. Clinical Genetics 15(6): 480-486
Nédélec, O.; Guérin, T. 1986: A pericoronal cyst developed attached to the lower wisdom tooth. Le Chirurgien-Dentiste de France 56(357): 81-82
Duda, D. 1990: A peridural catheter obstructed with glass particles--should a filter always be used in a test dose?. Regional-Anaesthesie 13(7): 186-187
Diaz Romero, R.M.; Barranco Jaubert, A.; Chavira Bautista, R.E. 1990: A perinatal approach to dental practice for diabetic women. Revista Adm 47(2): 67-70
Dahlberg, N.L. 1988: A perinatal center based antepartum homecare program. Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 17(1): 30-34
La Puma, J.; Darling, C.M.; Stocking, C.B.; Schiller, K. 1992: A perinatal ethics committee on abortion: process and outcome in thirty-one cases. Journal of Clinical Ethics 3(3): 196-203
Cope, I. 1987: A perinatal growth chart for international reference. Australian and New Zealand Journal of Obstetrics and Gynaecology 27(1): 45
Hernández, C.; Arias, J.E.; Gómez, L. 1986: A perinatal monitoring display based on the fetal topogram. IEEE Transactions on Bio-Medical Engineering 33(8): 785-792
Cavatorta, E. 1977: A perinatal mortality sample. Minerva Ginecologica 29(11): 866-868
Machin, G.A. 1975: A perinatal mortality survey in south-east London, 1970-73: the pathological findings in 726 necropsies. Journal of Clinical Pathology 28(6): 428-434
Courtney, K.D.; Andrews, J.E.; Springer, J.; Ménache, M.; Williams, T.; Dalley, L.; Graham, J.A. 1986: A perinatal study of toluene in CD-1 mice. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 6(1): 145-154
Boumghar, M. 1986: A perineal fistula of unusual origin. Schweizerische Rundschau für Medizin Praxis 75(36): 1056-1059
Das Gupta, P. 1977: A period analysis of parity distribution among white and nonwhite women in the United States, 1940-1974. Social Biology 24(4): 303-315
Cerny, J.; Henriet, Y. 1991: A period in the pediatric hospital of Iwiro, Zaire. Revue Medicale de Bruxelles 12(4): 147-151
Pierron, D.L. 1975: A period of rapid growth. Journal of the Michigan Dental Association 57(6): 259-260
Sukhanova, L.P.; Elizarova, I.P. 1986: A period of urgent postnatal adaptation as a critical stage of human ontogenesis. Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki 3: 45-52
Hallén Sandgren, C.; Mamo, W.; Larsson, I.; Lindahl, M.; Björk, I. 1991: A periodate-sensitive anti-phagocytic surface structure, induced by growth in milk whey, on Staphylococcus aureus isolated from bovine mastitis. Microbial Pathogenesis 11(3): 211-220
Cooke, P. 1985: A periodic cytoskeletal lattice in striated muscle. Cell and Muscle Motility 6: 287-313
Mikulecký, M. 1991: A periodic fluctuation in the false anti-HIV-1 reactivity of blood donors' sera--a worldwide phenomenon?. Acta Virologica 35(1): 108
Riven-Kreitman, R.; Tauber-Finkelstein, M.; Zipori, D.; Shaltiel, S. 1990: A periodicity in the response of SJL/J thymocytes to isoproterenol. Simulation by cell lines. Molecular and Cellular Endocrinology 73(2-3): 211-216
Meshcheriakov, V.A.; Shabaev, V.V. 1975: A periodogram analysis of the structure of a rhythmic stereotype of alimentary secretory conditioned reflexes. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 25(2): 421-423
Meister, F.; Lommel, T.J.; Davies, E.E. 1976: A periodontal abscess associated with vertical root fractures. Journal of the Wisconsin Dental Association 52(12): 562-563
Main, P.A. 1986: A periodontal index for dental health screening. Canadian Journal of Community Dentistry 1(2): 23-26
Martin, J.A. 1986: A periodontal point of view on dentist business. Pennsylvania Dental Journal 53(4): 20-21
Jeffcoat, M.K.; Jeffcoat, R.L.; Captain, K. 1991: A periodontal probe with automated cemento--enamel junction detection-design and clinical trials. IEEE Transactions on Bio-Medical Engineering 38(4): 330-333
Ashley, F.P. 1987: A periodontal view of radiology. Proceedings of the British Society of Dental and Maxillofacial Radiology 2: 13-15
Fagan, H.H. 1977: A periodontal view of splinting. District of Columbia Dental Society Journal. District of Columbia Dental Society 1977: 11-16
Oliver, R.C. 1976: A periodontist's view on the assessment of periodontal disease in the community. International Dental Journal 26(4): 435-440
Wood, W. 1991: A perioperative case study of frontal lobe meningioma. Journal of Post Anesthesia Nursing 6(4): 265-268
Mai-Lombardo, J. 1986: A perioperative program in ambulatory surgery for senior nursing students. AORN Journal 44(4): 648 650
Moushey, R.; Sinacore, M.L.; Diomede, B. 1988: A perioperative teaching program: a collaborative process. Journal of Pediatric Nursing 3(1): 40-45
DiNobile, C. 1988: A perioperative view: patients with chest tubes. Today's OR Nurse 10(8): 22-28
Spoor, T.C.; Ramocki, J.M.; Cowden, J.W. 1989: A periosteal-temporalis fascia pedicle flap for repairing impending ocular perforations and extruding keratoprostheses. American Journal of Ophthalmology 108(6): 704-708
Fleming, C.; Wong, J.B.; Moskowitz, A.J.; Pauker, S.G. 1988: A peripartum neurologic event: shooting from the hip. Medical Decision Making: An International Journal of the Society for Medical Decision Making 8(1): 55-71
Sela, M. 1987: A peripatetic and personal view of molecular immunology for one third of the century. Annual Review of Immunology 5: 1-19
Berendsen, H.H.; Broekkamp, C.L. 1991: A peripheral 5-HT1D-like receptor involved in serotonergic induced hindlimb scratching in rats. European Journal of Pharmacology 194(2-3): 201-208
Sulcová, A.; Krsiak, M. 1989: A peripheral antagonist of benzodiazepine receptors (PK 11195) did not reverse behavioural effects of diazepam in mice. Activitas Nervosa Superior 31(4): 295-296
Ceravolo, F.J.; Verbin, R.S.; Oakley, C.F. 1987: A peripheral giant cell granuloma associated with long-standing unusual gingival recession and labial radicular bone loss. Periodontal Case Reports: a Publication of the Northeastern Society of Periodontists 9(1): 21-23
Burkes, E.J.; White, R.P. 1989: A peripheral giant-cell granuloma manifestation of primary hyperparathyroidism: report of case. Journal of the American Dental Association 118(1): 62-64
Nurden, A.T. 1977: A peripheral high molecular weight glycoprotein located at the surface of human platelets. Experientia 33(3): 331-332
Whiteley, P.J.; Poindexter, N.J.; Landon, C.; Kapp, J.A. 1990: A peripheral mechanism preserves self-tolerance to a secreted protein in transgenic mice. Journal of Immunology 145(5): 1376-1381
Edell, D.J. 1986: A peripheral nerve information transducer for amputees: long-term multichannel recordings from rabbit peripheral nerves. IEEE Transactions on Bio-Medical Engineering 33(2): 203-214
Johansson, E.A.; Niemi, K.M.; Mustakallio, K.K. 1977: A peripheral vascular syndrome overlapping with systemic lupus erythematosus. Recurrent venous thrombosis and hemorrhagic capillary proliferation with circulating anticoagulants and false-positive seroreactions for syphilis. Dermatologica 155(5): 257-267
Dubner, R.; Sumino, R.; Wood, W.I. 1975: A peripheral "cold" fiber population responsive to innocuous and noxious thermal stimuli applied to monkey's face. Journal of Neurophysiology 38(6): 1373-1389
Clineschmidt, B.V.; Pettibone, D.J.; Lotti, V.J.; Hucker, H.B.; Sweeney, B.M.; Reiss, D.R.; Lis, E.V.; Huff, J.R.; Vacca, J. 1988: A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. Journal of Pharmacology and Experimental Therapeutics 245(1): 32-40
Mion, C. 1976: A peritoneal dialysis programme. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 12: 140-145
Marcovici, H.; Nicolcioiu, M.; Creţu, M.; Romoşan, I. 1989: A periventricular tumor associated with acute kidney failure and bilateral renal cortical necrosis. Revista de Medicina Interna Neurologie Psihiatrie Neurochirurgie Dermato-Venerologie. Neurologie Psihiatrie Neurochirurgie 34(2): 149-153
Anonymous 1990: A permanent US-Mexico border environmental health commission. Council on Scientific Affairs. JAMA 263(24): 3319-3321
Magovern, J.A.; Prophet, G.A.; Pae, W.E.; Pierce, W.S. 1988: A permanent arterial access system. Asaio Transactions 34(3): 460-462
Gordon, J.H.; Fields, J.Z. 1989: A permanent dopamine receptor up-regulation in the ovariectomized rat. Pharmacology Biochemistry and Behavior 33(1): 123-125
Pease, P.E.; Tallack, J.E. 1990: A permanent endoparasite of man. 1. the silent zoogleal/symplasm/L-form phase. Microbios 64: 260-261
Flageul, G.; Vial, P.; Gholam, D.; Clough, K.; Nicoletis, C. 1989: A permanent expanding prosthesis and the latest refinements in breast reconstructive surgery. Annales de Chirurgie Plastique et Esthetique 34(6): 489-492
Zhou, J.T. 1986: A permanent lead introduction technic: subclavian venipuncture and insertion of ventricular and/or atrial leads. Chinese Medical Journal 99(5): 397-400
Montesinos, A. 1987: A permanent learning experience in nursing units. Soins; la Revue de Reference Infirmiere 506: 53-56
Raza, A.; Kempski, M.; Preisler, H.D.; Block, A.W. 1985: A permanent method of detecting SCE by immunofluorescence using monoclonal anti-BrdU antibodies. Cancer Genetics and Cytogenetics 15(1-2): 187-189
Millstein, P.L. 1985: A permanent method of recording occlusal contacts. Journal of Prosthetic Dentistry 53(5): 748-749
Sułkowski, W.; Kowalska, S.; Lipowczan, A. 1986: A permanent noise-induced shift in the auditory threshold in textile industry workers. Medycyna Pracy 37(3): 175-186
Skeie, S.; Bae, E.A. 1989: A permanent pacemaker. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(17-18): 1883-1884
Andersen, C.; Oxhøj, H.; Arnsbo, P. 1989: A permanent pacemaker with variable frequency. Ugeskrift for Laeger 151(10): 640-641
Mayevsky, A.; Gassner, S.; Samuel, D. 1977: A permanent plastic cannula for intraventricular injections into rat brain. Journal of Neuroscience Research 3(1): 81-83
Lo, J.W.; Tess, B.R. 1975: A permanent record of antibiotic susceptibility results (disk method) using a Xerox photocopying machine. American Journal of Clinical Pathology 64(2): 271-272
Levander, H.; Anker, C. 1986: A permanent subcutaneous catheter for drawing blood samples and for intravenous fluid therapy in a diabetic woman with recurrent ketoacidosis. Upsala Journal of Medical Sciences 91(3): 323-324
Oesterling, J.E. 1991: A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results. Journal of Andrology 12(6): 423-428
Din, F.M. 1992: A permanently bondable matrix band for composite restorations. Compendium 13(10): 836; 838 840 Passim
Kasahara, M. 1977: A permeability change in Ehrlich ascites tumor cells caused by dextran sulfate and its repair by ascites fluid or Ca2+ ions. Archives of Biochemistry and Biophysics 184(2): 400-407
Sadowski, I.J.; Wright, J.A.; Israels, L.G. 1985: A permeabilized cell system for studying regulation of aryl hydrocarbon hydroxylase: NADPH as rate limiting factor in benzo(a)pyrene metabolism. International Journal of Biochemistry 17(9): 1023-1025
Miller, M.R.; Castellot, J.J.; Pardee, A.B. 1978: A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry 17(6): 1073-1080
Seki, S.; Lemahieu, M.; Mueller, G.C. 1975: A permeable cell system for studying DNA replication in synchronized Hela cells. Biochimica et Biophysica Acta 378(3): 333-343
Bell, D.R.; Reiszner, K.D.; West, P.W. 1975: A permeation method for the determination of average concentrations of carbon monoxide in the atmosphere. Analytica Chimica Acta 77: 245-254
Watzke, H.; Kovarik, J.; Gassner, H. 1988: A permissive effect of cyclosporin on the development of isohaemagglutinins of graft origin in ABO-mismatched organ transplantation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 3(1): 89-90
Haug, E.; Bjøro, T.; Gautvik, K.M. 1987: A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells. Journal of Steroid Biochemistry 28(4): 385-391
Okajima, F.; Sato, K.; Nazarea, M.; Sho, K.; Kondo, Y. 1989: A permissive role of pertussis toxin substrate G-protein in P2-purinergic stimulation of phosphoinositide turnover and arachidonate release in FRTL-5 thyroid cells. Cooperative mechanism of signal transduction systems. Journal of Biological Chemistry 264(22): 13029-13037
Balogh, E. 1986: A peroneal bone of atypical shape, simulating traumatic change. Magyar Traumatologia Orthopaedia Es Helyreallito Sebeszet 29(3): 238-239
Csendes, A.; Amdrup, E.; Parada, M. 1979: A peroperative technique for determining the extent of gastrectomy. Surgery Gynecology and Obstetrics 149(1): 81-83
O'Brien, P.J.; Rahimtula, A.D. 1978: A peroxidase assay for cytochrome P-450. Methods in Enzymology 52: 407-412
Goren, M.P.; Osborne, S.; Wright, R.K. 1986: A peroxidase-coupled kinetic enzymatic procedure evaluated for measuring serum and urinary creatinine. Clinical Chemistry 32(3): 548-551
Spillert, C.R.; Pelosi, M.A.; Parmer, L.P.; Lazaro, E.J. 1987: A peroxide-induced inflammation model for drug testing. Agents and Actions 21(3-4): 297-298
Adlakha, A.; Lobl, J.K. 1992: A perplexing case of diurnal edema in a young woman. Hospital Practice 27(9): 213-216
Poulos, C.; Dickson, H.G.; Lance, J.W.; Wilton, N.M. 1989: A perplexing deterioration in neurological function. Medical Journal of Australia 150(4): 202-205
Van Haelst, U.J.; de Haas van Dorsser, A.H. 1975: A perplexing malignant bone tumor. Highly malignant so-called adamantinoma or non-typical Ewing's sarcoma. Virchows Archiv. a Pathological Anatomy and Histology 365(1): 63-74
Grunewald, J.; Jeddi-Tehrani, M.; Dersimonian, H.; Andersson, R.; Wigzell, H. 1992: A persistent T cell expansion in the peripheral blood of a normal adult male: a new clinical entity?. Clinical and Experimental Immunology 89(2): 279-284
Schramm, M.; Rodbell, M. 1975: A persistent active state of the adenylate cyclase system produced by the combined actions of isoproterenol and guanylyl imidodiphosphate in frog erythrocyte membranes. Journal of Biological Chemistry 250(6): 2232-2237
Fraser, K.J.; Clarris, B.J.; Muirden, K.D.; Fraser, J.R.; Jack, I. 1985: A persistent adenovirus type 1 infection in synovial tissue from an immunodeficient patient with chronic, rheumatoid-like polyarthritis. Arthritis and Rheumatism 28(4): 455-458
Richter, E.; Pirsig, W.; Tänzer, A. 1975: A persistent craniopharyngeal canal combined with a meningoencephalocele. Hno 23(8): 240-245
Risling, M.; Lindå, H.; Cullheim, S.; Franson, P. 1989: A persistent defect in the blood-brain barrier after ventral funiculus lesion in adult cats: implications for CNS regeneration?. Brain Research 494(1): 13-21
Ehara, Y.; Moriwake, T.; Okamoto, M.; Sato, M. 1987: A persistent epileptogenic change induced by long-term Sylvian gyrus kindling in cats. Japanese Journal of Psychiatry and Neurology 41(3): 551-553
Herrera, M.A.; D'Souza, V.J.; Link, K.M.; Weesner, K.M.; Formanek, A.G. 1987: A persistent fifth aortic arch in man: a double-lumen aortic arch (presentation of a new case and review of the literature). Pediatric Cardiology 8(4): 265-269
Birnbaum, L.S.; McKinney, J.D. 1985: A persistent hexabromonaphthalene isomer is 2,3,4,5,6,7-hexabromonaphthalene. Journal of Toxicology and Environmental Health 16(2): 219-227
Welten, R.J.; Eikelboom, B.C.; Ackerstaff, R.G.; Ludwig, J.W. 1988: A persistent hypoglossal artery arising from the external carotid artery. European Journal of Vascular Surgery 2(4): 269-272
Truant, A.L.; Hallum, J.V. 1977: A persistent infection of baby hamster kidney-21 cells with mumps virus and the role of temperature-sensitive variants. Journal of Medical Virology 1(1): 49-67
Schwindt, P.; Crill, W.E. 1977: A persistent negative resistance in cat lumbar motoneurons. Brain Research 120(1): 173-178
Kinsella, D.; Norman, P. 1992: A persistent offender. British Journal of Radiology 65(769): 85-86
Heling, I.; Rotstein, I. 1989: A persistent oronasal sinus tract of endodontic origin. Journal of Endodontics 15(3): 132-134
Martha, P.M.; Blizzard, R.M.; McDonald, J.A.; Thorner, M.O.; Rogol, A.D. 1988: A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion. Journal of Clinical Endocrinology and Metabolism 67(3): 449-454
Kauer, J.A.; Malenka, R.C.; Nicoll, R.A. 1988: A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron 1(10): 911-917
Davis, R.E.; Stuart, A.E. 1988: A persistent, TTX-sensitive sodium current in an invertebrate neuron with neurosecretory ultrastructure. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 8(11): 3978-3991
Aulich, V. 1976: A person falling ill with acute leukemia; observations on the leukemia problem by a nurse. Krankenpflege 30(9): 258; 267-269
Mager, D.M. 1985: A person story: modern job hunting for nurses. Connecticut Nursing News 58(11): 5
Nadelson, T. 1978: A person's boundaries: a meaning of skin disease. Cutis 21(1): 90-93
Boucher, K. 1992: A person, not a disease. Imprint 39(4): 9
Chemers, M.M.; Hays, R.B.; Rhodewalt, F.; Wysocki, J. 1985: A person-environment analysis of job stress: a contingency model explanation. Journal of Personality and Social Psychology 49(3): 628-635
Inouye, D.; Inouye, D. 1977: A personal account (Senator Daniel Inouye). Arn Journal: the Official Journal of the Association of Rehabilitation Nurses 2(1): 7; 14
Smithells, P. 1978: A personal account by a sufferer from a stroke. New Zealand Medical Journal 87(613): 396-397
Henningsen, A. 1992: A personal account. Via twisted ways toward burnout. Fag Tidsskriftet Sykepleien 80(3): 39-41
Hill, R.H.; Arnold, J.E. 1979: A personal air sampler for pesticides. Archives of Environmental Contamination and Toxicology 8(5): 621-628
Carter, K.B.; Halliday, M.M. 1978: A personal air sampling pump for hospital operating staff. Journal of Medical Engineering and Technology 2(6): 310-312
Goulston, S.J.; McGovern, V. 1985: A personal appreciation of Dr. Vincent McGovern. Pathology 17(2): 151
Lonergan, R.C. 1985: A personal approach to caries prevention in private practice. Journal of the New Zealand Society of Periodontology 60: 8-9
Wasinger, J.L. 1986: A personal approach to dental care for patients with handicapping conditions. Special Care in Dentistry: Official Publication of the American Association of Hospital Dentists the Academy of Dentistry for the Handicapped and the American Society for Geriatric Dentistry 6(4): 156-159
Lysaght, L. 1979: A personal bereavement. New Zealand Nursing Journal. Kai Tiaki 72(11): 22
Giordano, G.; Croce, C.; Di Lucrezia, F. 1976: A personal case of intracavitary fibroleiomyoma. Minerva Ginecologica 28(2): 150-153
Appiotti, A.; Bacci, R.; Daniele, D.; Inglezis, A.; Trebini, F. 1992: A personal case report of subacute sclerosing panencephalitis in an adult. Minerva Medica 83(7-8): 479-483
Ayalon, V. 1992: A personal challenge: the Nurse in Washington Internship (NIWI). Journal of emergency nursing 18(5): 457-458
Nishizawa, K.; Ozawa, T. 1987: A personal computer access control system for radioisotope laboratories. Health Physics 53(5): 537-539
Levay, E.J.; Netzel, C. 1990: A personal computer assessment program for increased risk in life insurance. Versicherungsmedizin 42(1): 9-11
Roysam, B.; Maffitt, D.R.; Miller, M.I.; Saffitz, J.E.; Thomas, L.J. 1992: A personal computer based implementation of the maximum-likelihood method of analysis of electron microscope autoradiographs. Microscopy Research and Technique 20(1): 73-86
Schloeffel, P.R. 1988: A personal computer database system for head and neck cancer records. Journal of Medical Systems 12(1): 43-55
Winkler, G.; Heinz, F.X.; Kunz, C. 1986: A personal computer program using a 4-component logit for the evaluation of ELISA calibration curves with unknown asymptotic values. Computer Methods and Programs in Biomedicine 22(2): 167-170
Takada, K.; Nagata, M.; Hiraki, T.; Sakuda, M. 1988: A personal computer-assisted automated analysis system of masticatory muscle activity, jaw movement, and bite force. Journal of Osaka University Dental Society 33(1): 254-266
Ikeda, N.; DeLand, E.C.; Miyahara, H.; Takeuchi, A.; Yamamoto, H.; Sato, T. 1988: A personal computer-based arrhythmia generator based on mathematical models of cardiac arrhythmia. Journal of Electrocardiology 21 Suppl: S122-S128
Raouf, A.; al-Jumah, Y.A.; Duffuaa, S.O. 1990: A personal computer-based maintenance management expert system for hospitals. Journal of Medical Systems 14(3): 119-128
Takada, K.; Nagata, M.; Sakuda, M. 1988: A personal computer-based on-line biosignal processing in clinical orthodontics. Journal of Osaka University Dental School 28: 83-97
Bergman, H.; DeLong, M.R. 1992: A personal computer-based spike detector and sorter: implementation and evaluation. Journal of Neuroscience Methods 41(3): 187-197
Stoll, M.; Hamann, G.; Jost, V.; Schimrigk, K. 1992: A personal computer-based system for online monitoring of neurologic intensive care patients. Biomedizinische Technik. Biomedical Engineering 37(3): 37-41
Shah, S.J.; Diller, K.R.; Aggarwal, S.J. 1987: A personal computer-based temperature control system for cryomicroscopy. Cryobiology 24(2): 163-168
Achour, H.; Thameur, H.; Jerbi, A.; Houissa, R.; Mestiri, S. 1978: A personal conception of so-called mediterranean cirrhosis in the light of 20 years' experience of portal surgery (98 cases). Chirurgie; Memoires de l'Academie de Chirurgie 104(5): 448-460
Richardson, G.; Cohen, J.B.; McPhate, D.C.; Hayes, P.A. 1988: A personal conditioning system based on a liquid-conditioned vest and a thermoelectric supply system. Ergonomics 31(7): 1041-1047
Neimeyer, R.A.; Neimeyer, G.J. 1977: A personal construct approach to perception of disclosure targets. Perceptual and Motor Skills 44(3 Part 1): 791-794
Sheehan, M.J. 1985: A personal construct study of depression. British Journal of Medical Psychology 58: 119-128
Jones, A.R. 1975: A personal contamination monitor using large area Geiger counters. Health Physics 28(5): 521-527
Ruholl, L.H. 1988: A personal difference. Proud to care. Chart 85(5): 13
Lopis, R. 1991: A personal encounter with a mystery illness. Australian Family Physician 20(3): 316-317
Bailey, D. 1991: A personal experience. Prosthetics and Orthotics International 15(2): 162
Heyat, J. 1979: A personal experience of 522 thyroidectomies. Chirurgie; Memoires de l'Academie de Chirurgie 105(8): 635-641
Curjel, H.E. 1979: A personal experience of a naval hunger strike. Journal of the Royal Naval Medical Service 65(1): 33-34
Stott, M. 1985: A personal experience of ageing. Nursing 2(41): 1203-1205
Lundin, P. 1990: A personal experience of twenty-four years of dialysis. Transplantation Proceedings 22(3): 957-958
Coran, A.G. 1990: A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults. Annals of Surgery 212(3): 242-247; Discussion: 247-248
Fujita, K. 1978: A personal experience with 643 transurethral resections. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 69(5): 611-614
Keen, L.M. 1986: A personal experience with AIDS. Courageous patient shares his ordeal through newspaper. American Journal of Hospice Care 3(2): 10-16
Shearn, M.A.; Shearn, L. 1986: A personal experience with Guillain-Barré syndrome: are the psychologic needs of patient and family being met?. Southern Medical Journal 79(7): 800-803
Yeoh, N.; Inbasegaran, K. 1989: A personal experience with the first 100 TURP at the Penang General Hospital. Medical Journal of Malaysia 44(2): 129-133
Beiser, H.R. 1985: A personal experience: The Medical Disciplinary Board. Illinois Medical Journal 168(1): 45-48
Brown, T. 1988: A personal filing system for indexing reprints, documents, and other items. Australian Dental Journal 33(3): 231-236
Kuwano, T. 1975: A personal history of a nursing instructor. Japanese Journal of Nurses' Education 16(3): 129-133
Sapira, J.D. 1990: A personal history of the ectopic brain. Southern Medical Journal 83(10): 1203-1204
Hirschowitz, B.I.; Hirschowitz, B.I. 1979: A personal history of the fiberscope. Gastroenterology 76(4): 864-869
Lehfeldt, H. 1987: A personal history of the progress in contraception during the past 60 years. Midwife Health Visitor and Community Nurse 23(7): 282-285
Miller, K.L. 1992: A personal journey through the abyss of depression. Journal of Practical Nursing 42(3): 8-10
Raine, C.S.; Bruyn, G.W. 1992: A personal letter to George Bruyn, the Editor. Clinical Neurology and Neurosurgery 94 Suppl: S143
Warren, C. 1988: A personal look at crying babies. Midwife Health Visitor and Community Nurse 24(12): 517; 520
Vogel, W. 1991: A personal memoir of the state hospitals of the 1950s. Hospital and Community Psychiatry 42(6): 593-597
Barsky, A.J.; Barsky, A.J. 1978: A personal memoir: plastic surgery in the twentieth century. Surgical Clinics of North America 58(5): 1019-1029
Michael, H.R. 1977: A personal memory helped me care. Rn 40(2): 56-66
Muratori, G. 1979: A personal method for the systematic reimplantation of the biradiculars and triradiculars. Journal of Oral Implantology 8(4): 604-610
Serwatka, F. 1978: A personal method of early prosthetic management after partial maxillectomy (preliminary report). Protetyka Stomatologiczna 28(5): 333-336
De Marchi, E. 1977: A personal method of osteotomy of the pelvis. La Chirurgia Degli Organi di Movimento 63(5): 423-425
McPherson, D.E. 1986: A personal myth--Yukio Mishima: the Samurai Narcissus. Psychoanalytic Review 73(3): 361-379
Shumacker, H.B. 1985: A personal overview of causalgia and other reflex dystrophies. Annals of Surgery 201(3): 278-289
Levenson, D. 1976: A personal overview of toroidal contact lenses. Journal of the American Optometric Association 47(3): 323
Mellow, J. 1986: A personal perspective of nursing therapy. Hospital and Community Psychiatry 37(2): 182-183
Lenz, W.; Lenz, W. 1992: A personal perspective on the thalidomide tragedy. Teratology 46(5): 417-418
Massey, P. 1990: A personal perspective--our strength comes from within. Florida Nurse 38(1): 8
Malecki, M.S. 1987: A personal perspective: working with families who donate organs and tissues. Ad Nurse 2(4): 12-14
Melbye, H.; Aaraas, I. 1990: A personal physician, wishes and realities in Northern Norway. a patient study in Northern Norway in 1987. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(27): 3482-3484
Kanno, T.; Ishiyama, N.; Tanji, H.; Sano, H.; Abe, M.; Kamei, Y.; Asai, T.; Nakagawa, T.; Jain, V.K. 1987: A personal point of view to EC-IC bypass surgery in completed stroke after the co-operative study. No Shinkei Geka. Neurological Surgery 15(12): 1299-1303
Leuschner, R.M.; Boehm, G. 1977: A personal pollen trap. Preliminary report. Schweizerische Medizinische Wochenschrift 107(2): 57-59
Mantero, E.; Bagnoli, L.; Parini, A.; Pianetti, F.; Mantero, M.; Ballerini, G.; Longatti, A.; Cortese, G. 1977: A personal radiopelvimetric technique. La Radiologia Medica 63(7-8): 629-634
Caspi, E.; Nes, W.R. 1989: A personal recollection: professor William Robert Nes (1926-1988). Steroids 53(3-5): Vii-Vix
Adams, C.E.; Bayne, T. 1992: A personal recovery program for codependent nurse practitioners. Nurse Practitioner 17(2): 72-75
Engstrom, B.; Nygaard-Ostby, B. 1977: A personal reminiscence. Journal of Endodontics 3(11): 437
Guillemin, R.; Selye, H. 1985: A personal reminiscence of Hans Selye. Experientia 41(5): 560-561
Tanaka, K.; Konagaya, K. 1985: A personal review of anesthetic management in dentistry for the severely handicapped in the Okinawa District. Aichi Gakuin Daigaku Shigakkai Shi 23(2): 486-493
Tanaka, I.; Akiyama, T. 1985: A personal sampling and an area sampling--exposure concentration and environmental concentration. Journal of Uoeh 7(2): 207-211
Negron, A.E.; Bruno, M.S.; Ortiz, J.G. 1988: Proline binding to mouse brain synaptosomes. Puerto Rico Health Sciences Journal 7(2): 101-103
Rothrock, J.C. 1985: A personal story about malignant melanoma. the impact of one OR nurse. AORN Journal 42(1): 51-52
Galaĭ, I.P.; Kukhlevskiĭ, V.S.; Ul'ianov, S.V. 1989: A personal system of automated planning of microprocessor printing plates for radio-electronic medical equipment. Meditsinskaia Tekhnika 3: 42-48
Menendez Felipe, J.V. 1985: A personal technic for high fixation in craniofacial fractures. Revista de Actualidad Estomatologica Espanola 45(349): 43-45
Alejo Enrici, E.; Krapp, J.C.; Ciucci, J.L. 1989: A personal technic using a pediculate flap in the treatment of postmastectomy lymphedema. Angiologia 41(3): 112-116
Brunelli, G.A.; Brunelli, G.R. 1991: A personal technique for treatment of scaphoid non-union. Journal of Hand Surgery 16(2): 148-152
Anderson, J.R. 1975: A personal technique of rhinoplasty. Otolaryngologic Clinics of North America 8(3): 559-562
Platt, H.; Bruce, J. 1977: A personal tribute. Journal of the Royal College of Surgeons of Edinburgh 22(1): 3-4
Austin, B.; Dickinson, C.H.; Goodfellow, M. 1977: Antagonistic interactions of phylloplane bacteria with Drechslera dictyoides (Drechslera) Shoemaker. Canadian Journal of Microbiology 23(6): 710-715
Scavelli, V.; Veneziani, P.; Vestita, G.; Manghisi, D.; Sorino, F.; Gabrieli, G. 1989: A personal variant of the Vayre and Petit Pazos technique in the surgical repair of inguinal hernia. Il Giornale di Chirurgia 10(9): 477-480
Gately, R. 1990: A personal view of a man-made disaster: Afghanistan. Journal of Emergency Nursing 16(4): 69a-73a
Terblanche, J. 1986: A personal view of advances in biliary tract surgery. South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 24(3): 85-92
Horsley, E.D. 1987: Growing old, not unhealthy. Health Visitor 60(8): 258-259
Gickling, E.E.; Thompson, V.P. 1985: A personal view of curriculum-based assessment. Exceptional Children 52(3): 205-218
Fromm, A. 1975: A personal view of dental education in the U.S.S.R. Journal 54(6): 8-10
Hogan, B. 1989: A personal view of independent living. Rehabilitation Nursing: the Official Journal of the Association of Rehabilitation Nurses 14(1): 30-31
DuVal, M.K. 1979: A personal view of medicine in the U.S., past present and future. Arizona Medicine 36(4): 284-286
Mew, J. 1989: A personal view of oral myofunctional therapy in Britain. International Journal of Orofacial Myology: Official Publication of the International Association of Orofacial Myology 15(2): 15-16
Magides, A.D. 1991: A personal view of postdural puncture headache. Anaesthesia 46(8): 694
Quen, J.M.; Diamond, B.L. 1992: A personal view of the ethics and values of Bernard L. Diamond. Bulletin of the American Academy of Psychiatry and the Law 20(2): 133-139
Maguire, J. 1992: A personal view of the hospital service. Ulster Medical Journal 61(1): 59-62
Turner-Warwick, R. 1977: A personal view of the immediate management of pelvic fracture urethral injuries. Urologic Clinics of North America 4(1): 81-93
Turner-Warwick, R. 1977: A personal view of the management of traumatic posterior urethral strictures. Urologic Clinics of North America 4(1): 111-124
Simpson, J.S. 1979: A personal view: the R.A.C.S. Foundation. Australian and New Zealand Journal of Surgery 49(6): 683-684
Bates, B.F. 1988: A personal-computer reporting system for mammography. Ajr. American Journal of Roentgenology 151(6): 1237-1239
Bongi, S.M. 1992: A personalised splint for osteoarthritis. Nursing Times 88(7): 46-47
Kegel-Flom, P. 1977: A personality profile of "Gold Retinoscope" winners: 1961-1975. American Journal of Optometry and Physiological Optics 54(4): 208-211
Scribner, B.H.; Scribner, B.H. 1990: A personalized history of chronic hemodialysis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 16(6): 511-519
Clark, L.C.; Clark, E.W. 1987: A personalized history of the Clark oxygen electrode. International Anesthesiology Clinics 25(3): 1-29
Zencius, A.H.; Davis, P.K.; Cuvo, A.J. 1990: A personalized system of instruction for teaching checking account skills to adults with mild disabilities. Journal of Applied Behavior Analysis 23(2): 245-252
Smith, E.F.; Uys, H.H. 1991: A personnel profile of professional nurses in the J.D. Allen Operating Theatre Complex of Baragwanath Hospital. Curationis 14(3): 27-35
Sandson, J.I. 1977: A perspecitve on education in nutrition. American Journal of Clinical Nutrition 30(5): 822-824
LeNoir, J.L. 1976: A perspective focus on the indicated surgical treatment of resistant clubfoot in the infant. Southern Medical Journal 69(7): 837-843
Kodama, K.; Kodama, S. 1987: A perspective for effective cooperation. Japanese Journal of Nursing 39(4): 18-25
Shaw, A.; Shaffer, H.; Teja, K.; Kelly, T.; Grogan, E.; Bruni, C. 1979: A perspective for pediatric surgeons: chronic idiopathic intestinal pseudoobstruction. Journal of Pediatric Surgery 14(6): 719-727
Henderson, J.M. 1989: A perspective for the management of variceal bleeding. British Journal of Surgery 76(4): 323-324
Jackson, G.G. 1976: A perspective from controlled investigations of chemotherapy for viral respiratory infections. Journal of Infectious Diseases 133 Suppl: A83-A92
Haddow, A.; Haddow, A. 1975: A perspective in time. Perspectives in Biology and Medicine 18(4): 433-455
Jones, J.F. 1989: A perspective of Epstein-Barr virus diseases. Advances in Pediatrics 36: 307-345
Quenzer, R.W. 1987: A perspective of cephalosporins in pneumonia. Chest 92(3): 531-535
Forrester, J.S.; Litvack, F.; Grundfest, W.; Hickey, A. 1987: A perspective of coronary disease seen through the arteries of living man. Circulation 75(3): 505-513
Emanuel, R. 1978: A perspective of hypertrophic cardiomyopathy. Indian Heart Journal 30(3): 127-133
Shapiro, S. 1976: A perspective of infant and fetal mortality in the developed countries. World Health Statistics Report. Rapport de Statistiques Sanitaires Mondiales 29(2): 96-116
Indelicato, P.A.; Bittar, E.S. 1985: A perspective of lesions associated with ACL insufficiency of the knee. a review of 100 cases. Clinical Orthopaedics and Related Research 198: 77-80
Rix, B. 1986: A perspective of mental handicap. Journal of the Royal Society of Health 106(5): 161-165
Krause, M.E. 1978: A perspective of motivating factors in the retention of Army orthopaedic personnel. Military Medicine 143(1): 36-38
Burn, J.M. 1976: Medical disease and the anaesthetist. Proceedings of the Royal Society of Medicine 69(12): 949
Holden, W.D. 1979: A perspective of physician manpower. New England Journal of Medicine 300(9): 493-495
Krueger, G.G. 1989: A perspective of psoriasis as an aberration in skin modified to expression by the inflammatory/repair system. Immunology Series 46: 425-445
Kaufmann, A.F.; Moulthrop, J.I.; Moore, R.M. 1975: A perspective of simian tuberculosis in the United States-1972. Journal of Medical Primatology 4(5): 278-286
Alexander, E. 1987: A perspective of the 1940s. Surgical Neurology 28(4): 319-320
Parker, W.S. 1985: A perspective of the Crozat appliance with case reports of its present use. American Journal of Orthodontics 88(1): 1-21
Bonett, A.; Roder, D.; MacHarper, T. 1986: A perspective of the cancer problem in South Australia. Community Health Studies 10(3): 330-335
Chen, K. 1992: A perspective of the clinical research on traditional Chinese medicine in the treatment of cardiovascular diseases in the 1990s. Journal of Traditional Chinese Medicine 12(2): 83-87
Gangarosa, E.J. 1976: A perspective of the global problem of enteric diseases, 1975. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 80(5): 397-402
Fennell, W.M. 1991: A perspective on AIDS. South African Medical Journal 79(10): 626
Laflamme, G. 1986: A perspective on Nicaragua. Canadian Nurse 82(7): 27-30
Gangahar, D.M. 1986: A perspective on PTCA. Nebraska Medical Journal 71(3): 54-55
Rich, P.R. 1986: A perspective on Q-cycles. Journal of Bioenergetics and Biomembranes 18(3): 145-156
Vorhees, C.V. 1989: A perspective on Tachibana's eta-squared analysis of the results of the NCTR collaborative behavioral teratology study. Psychological Reports 65(3 Pt 1): 819-823
Johnston, M.V.; Findley, T.W. 1990: A perspective on Wright and Linacre. Archives of Physical Medicine and Rehabilitation 71(6): 439-440
Carter, S.K. 1979: A perspective on adjuvant chemotherapy of testicular cancer. Journal of Cancer Research and Clinical Oncology 95(1): 1-9
Darabi, K.F.; Philliber, S.G.; Rosenfield, A. 1979: A perspective on adolescent fertility in developing countries. Studies in Family Planning 10(10): 300-303
Biglieri, E.G. 1976: A perspective on aldosterone abnormalities. Clinical Endocrinology 5(4): 399-410
Campbell, D.H. 1989: A perspective on alternative delivery systems. Journal of the Medical Association of Georgia 78(1): 21-22
Greenlee, W.F.; Andersen, M.E.; Lucier, G.W. 1991: A perspective on biologically-based approaches to dioxin risk assessment. Risk Analysis: An Official Publication of the Society for Risk Analysis 11(4): 565-568
Spiro, H.M. 1989: A perspective on careers in academic medicine. Archives of Internal Medicine 149(4): 969: 972
Gee, W. 1987: A perspective on carotid endarterectomy: comments. Journal of Vascular Surgery 5(6): 893-894
Sandoval, V.A. 1989: A perspective on chemical dependency in the health professions. New Mexico Dental Journal 40(2): 8-9; 11-12
Gorman, W.F. 1979: A perspective on child abuse. Arizona Medicine 36(6): 453-454
Bergsjø, P. 1988: A perspective on childbirth at home and in hospitals. Nordisk Medicin 103(3): 97-101
Goldberg, S.J. 1989: A perspective on color-coded Doppler echocardiography: utility or just another pretty picture?. Journal of the American College of Cardiology 14(4): 977-978
Anonymous 1985: A perspective on corporatization. American Family Physician 32(3): 87-88
Kolata, G. 1986: A perspective on degenerative brain disease. Science 232(4755): 1197
McLean, J.W. 1989: A perspective on dentistry today. Australian Dental Journal 34(2): 175-180
Travis, C.C.; Hattemer-Frey, H.A. 1989: A perspective on dioxin emissions from municipal solid waste incinerators. Risk Analysis: An Official Publication of the Society for Risk Analysis 9(1): 91-97
Rozin, P.; Fallon, A.E. 1987: A perspective on disgust. Psychological Review 94(1): 23-41
Ayash, L.J.; Antman, K.; Cheson, B.D. 1991: A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors. Oncology 5(3): 25-33; Discussion 33 36 41
Barnes, G. 1975: A perspective on drinking among teenagers with special reference to New York State studies. Journal of School Health 45(7): 386-389
Glass, R.I. 1975: A perspective on environmental health in the USSR: research and practice. Archives of Environmental Health 30(8): 391-395
Tymchuk, A.J. 1976: A perspective on ethics in mental retardation. Mental Retardation 14(6): 44-47
Murray, T.M. 1990: A perspective on fluoride and the treatment of osteoporosis. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 5(Suppl 1): S1-S4
Watkins, J.E.; Weyhenmeyer, J.A. 1988: A perspective on health benefits. Hypertension therapy. Illinois Medical Journal 174(6): 350-352
Sablosky, A.; Studley, J. 1976: A perspective on health care and women in the Mississippi delta. Women and Health 1(4): 21-23
Hirshman, H.P.; Schurman, D.J.; Calin, A. 1978: Neutropenia and rheumatoid arthritis. Western Journal of Medicine 129(3): 235-236
Williams, H. 1977: A perspective on health on the Navajo Indian reservation. Journal of the Tennessee Medical Association 70(7): 475-480
Thomas, R.K. 1988: A perspective on hospital affiliation by optometrists. Journal of the American Optometric Association 59(8): 590-591
Volpé, R. 1992: A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder?. Autoimmunity 13(1): 3-9
Raddin, J.H. 1987: A perspective on human performance as the limiting factor in aircraft performance. Aviation Space and Environmental Medicine 58(5): 393-394
Imperato, P.J. 1986: A perspective on influenza control. Lancet 1(8483): 728-730
Hopp, J.W. 1990: A perspective on international school health education research. Journal of School Health 60(7): 379-382
Hui, S.E. 1979: A perspective on laboratory medicine. Annals of the Academy of Medicine Singapore 8(2): 115-117
Guttmann, R.D. 1987: A perspective on long-term outcome in organ transplantation. Transplantation Proceedings 19(1 Part 1): 67-73
Hendelman, W.J. 1991: A perspective on medical education: a return to clinical residency. Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 54(4): 2-7
Ravreby, M.D. 1976: A perspective on medical liability. Journal of the Iowa Medical Society 66(11): 440; 442
Federman, D.D. 1991: A perspective on medical student education for internal medicine. Annals of Internal Medicine 114(1): 90
Kollman, P.; Singh, U.C.; Lybrand, T.; Rao, S.; Caldwell, J. 1985: A perspective on molecular mechanical and molecular dynamical studies involving DNA. Progress in Clinical and Biological Research 172a: 173-185
Holder, L. 1975: A perspective on non-traditional academic programs in the health sciences. Health Education Monographs 3(3): 262-266
Nolan, D.L. 1988: A perspective on operational medical readiness. Military Medicine 153(10): 526-529
Oleske, J.M.; Connor, E.M.; Boland, M.G. 1988: A perspective on pediatric AIDS. Pediatric Annals 17(5): 319-321
Listgarten, M.A. 1986: A perspective on periodontal diagnosis. Journal of Clinical Periodontology 13(3): 175-181
Hausmann, E.; Jeffcoat, M. 1988: A perspective on periodontal disease activity measurements. Journal of Clinical Periodontology 15(2): 134-136
Wilson, C.S. 1992: A perspective on pre-medical education. Nebraska Medical Journal 77(1): 1
Drummond, D.S. 1991: A perspective on recent trends for scoliosis correction. Clinical Orthopaedics and Related Research 1991(264): 90-102
Heming, D.A. 1976: A perspective on relevance in pharmaceutical education. American Journal of Pharmaceutical Education 40(2): 167-170
Bener, A.; Jadaan, K.S. 1992: A perspective on road fatalities in Jeddah, Saudi Arabia. Accident; Analysis and Prevention 24(2): 143-148
Harlan, W.R. 1989: A perspective on school-based cardiovascular research. Health Education Quarterly 16(2): 151-154
Gordis, E. 1988: A perspective on science and public health policy. Public Health Reports 103(6): 575-577
Garfinkel, B.D.; Amrami, K.K. 1992: A perspective on the attention-deficit disorders. Hospital and Community Psychiatry 43(5): 445-6 448
Dorsey, D.B. 1978: A perspective on the autopsy. American Journal of Clinical Pathology 69(2 Suppl): 217-219
Brown, J.P. 1987: A perspective on the caries decline. Dental School Quarterly 3(3): 1-4
White, F.M. 1976: A perspective on the control of communicable diseases in Canada. Canadian Journal of Public Health 67(6): 449-459
Champion, G.D. 1988: A perspective on the cost-effectiveness and risks of non-steroidal anti-inflammatory drug therapy. Medical Journal of Australia 149(7): 346-349
Russell, L.M. 1989: A perspective on the debate over scientific misconduct. Clinical Research 37(2): 177-178
Danne, P.D. 1988: A perspective on the early management of abdominal trauma. Australian and New Zealand Journal of Surgery 58(11): 851-858
Iglehart, J.K. 1988: A perspective on the future of infectious disease reimbursement. Bulletin of the new York Academy of Medicine 64(6): 577-590
Gangarosa, E.J. 1977: A perspective on the global problem of enteric diseases. Bulletin of the Pan American Health Organization 11(1): 3-7
DeHovitz, J.A. 1986: A perspective on the heterosexual transmission of the acquired immunodeficiency syndrome. New York State Journal of Medicine 86(3): 117-118
Neu, H.C.; Chin, N.X. 1985: A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance. Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 4(1): 63-70
Morady, F. 1988: A perspective on the role of catheter ablation in the management of tachyarrhythmias. Pacing and Clinical Electrophysiology: Pace 11(1): 98-102
Bauer, E.A.; Tabas, M. 1988: A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa. Archives of Dermatology 124(5): 734-736
Habbema, J.D.; Van der Maas, P.J.; Dippel, D.W. 1986: A perspective on the role of decision analysis in clinical practice. Annales de Medecine Interne 137(3): 267-273
Pocock, S.J. 1991: A perspective on the role of quality-of-life assessment in clinical trials. Controlled Clinical Trials 12(4 Suppl): 257s-265s
Dustan, H.P. 1991: A perspective on the salt-blood pressure relation. Hypertension 17(1 Suppl): I166-I169
Kavet, J. 1977: A perspective on the significance of pandemic influenza. American Journal of Public Health 67(11): 1063-1070
Pearson, R.J. 1992: A perspective on the status of health care in West Virginia. West Virginia Medical Journal 88(11): 494-497
Rahimtoola, S.H. 1985: A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72(6 Part 2): V123-V135
Joffe, R.T. 1990: A perspective on the thyroid and depression. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 35(9): 754-758
Meyen, E.L.; Moran, M.R. 1979: A perspective on the unserved mildly handicapped. Exceptional Children 45(7): 526-530
Singh, N. 1987: A perspective on therapeutic work with in-patient adolescents. Journal of Adolescence 10(2): 119-131
Neu, H.C. 1988: A perspective on therapy of Lyme infection. Annals of the new York Academy of Sciences 539: 314-316
Williams, T.F. 1985: A perspective on training for academic leadership in geriatrics. Journal of the American Geriatrics Society 33(3): 163-166
Dimsdale, J.E. 1988: A perspective on type A behavior and coronary disease. New England Journal of Medicine 318(2): 110-112
Waldo, A.L.; Henthorn, R.W.; Carlson, M.D. 1990: A perspective on ventricular arrhythmias: patient assessment for therapy and outcome. American Journal of Cardiology 65(4): 30b-35b
Brown, S.A. 1985: A perspective on why nurses should earn doctorates in nursing. Perspectives in Psychiatric Care 23(1): 16-21
Sollitto, R.J.; Napoli, R.C.; Gazivoda, P.L.; Hart, T.J. 1989: A perspective study using bleomycin sulfate in the treatment of plantar verrucae. Journal of Foot Surgery 28(2): 141-144
Burgoyne, M. 1986: A perspective: health care in a politically oppressive environment. North Carolina Medical Journal 47(7): 349-351
Deuschle, K.W. 1985: A perspective: health services research at Mount Sinai Medical Center, NY. Mount Sinai Journal of Medicine new York 52(9): 677-678
Spencer, R.P. 1991: A perspective: in vivo assay of receptor-ligand binding. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 32(6): 1182-1183
Kress, H.; Nason, F. 1976: A perspective: the interdisciplinary approach to patients with chronic disease. Journal of the American Association of Nephrology Nurses and Technicians 3(1): 38-41
Champ, C.S.; Mason, C.H.; Coghill, S.B.; Robinson, M. 1989: A perspex grid for localization of non-palpable mammographic lesions in breast biopsies. Histopathology 14(3): 311-315
Grundström, N.; Karlsson, J.O.; Svensson, S.P.; Andersson, R.G. 1990: A pertussis toxin resistant alpha 2-adrenoceptor pathway in fish melanophores. Life Sciences 46(15): 1099-1101
Steinberg, S.F.; Chow, Y.K.; Robinson, R.B.; Bilezikian, J.P. 1987: A pertussis toxin substrate regulates alpha 1-adrenergic dependent phosphatidylinositol hydrolysis in cultured rat myocytes. Endocrinology 120(5): 1889-1895
Goh, J.W.; Pennefather, P.S. 1989: A pertussis toxin-sensitive G protein in hippocampal long-term potentiation. Science 244(4907): 980-983
Bueb, J.L.; Mousli, M.; Landry, Y.; Bronner, C. 1990: A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin. Agents and Actions 30(1-2): 98-101
Luttrell, L.; Kilgour, E.; Larner, J.; Romero, G. 1990: A pertussis toxin-sensitive G-protein mediates some aspects of insulin action in BC3H-1 murine myocytes. Journal of Biological Chemistry 265(28): 16873-16879
Pratt, B.L.; Takahashi, J.S. 1988: A pertussis toxin-sensitive G-protein mediates the alpha 2-adrenergic receptor inhibition of melatonin release in photoreceptive chick pineal cell cultures. Endocrinology 123(1): 277-283
Thomas, C.P.; Kester, M.; Dunn, M.J. 1991: A pertussis toxin-sensitive GTP-binding protein couples endothelin to phospholipase C in rat mesangial cells. American Journal of Physiology 260(3 Part 2): F347-F352
Lad, P.M.; Olson, C.V.; Grewal, I.S.; Scott, S.J. 1985: A pertussis toxin-sensitive GTP-binding protein in the human neutrophil regulates multiple receptors, calcium mobilization, and lectin-induced capping. Proceedings of the National Academy of Sciences of the United States of America 82(24): 8643-8647
Fujinaga, Y.; Morozumi, N.; Sato, K.; Tokumitsu, Y.; Fujinaga, K.; Kondo, Y.; Ui, M.; Okajima, F. 1989: A pertussis toxin-sensitive GTP-binding protein plays a role in the G0-G1 transition of rat hepatocytes following establishment in primary culture. Febs Letters 245(1-2): 117-121
Chaffin, K.E.; Perlmutter, R.M. 1991: A pertussis toxin-sensitive process controls thymocyte emigration. European Journal of Immunology 21(10): 2565-2573
Fulginiti, V.A. 1990: A pertussis vaccine myth dies. American Journal of Diseases of Children 144(8): 860-861
Sontag, J.M.; Thierse, D.; Rouot, B.; Aunis, D.; Bader, M.F. 1991: A pertussis-toxin-sensitive protein controls exocytosis in chromaffin cells at a step distal to the generation of second messengers. Biochemical Journal 274: 339-347
Xuan, Y.T.; Su, Y.F.; Chang, K.J.; Watkins, W.D. 1987: A pertussis/cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell. Biochemical and Biophysical Research Communications 146(2): 898-906
Verghese, M.; Uhing, R.J.; Snyderman, R. 1986: A pertussis/choleratoxin-sensitive N protein may mediate chemoattractant receptor signal transduction. Biochemical and Biophysical Research Communications 138(2): 887-894
Torres, E.R. 1991: A perversion named desire. International Journal of Psycho-Analysis 72: 73-92
Grider, P.C. 1990: A pessimistic outlook. Journal of the Kentucky Medical Association 88(5): 249
Brandt, K.D. 1989: A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers. Journal of Rheumatology. Suppl 18: 39-42
Hamilton, H.E.; Morgan, D.P.; Simmons, A. 1978: A pesticide (dieldrin)-induced immunohemolytic anemia. Environmental Research 17(2): 155-164
Anonymous 1988: A petition to the Board of Pharmaceutical Specialties requesting recognition of nutritional support pharmacy practice as a specialty. American Pharmacy 28(3): 80-89
Anonymous 1988: A petition to the Board of Pharmaceutical Specialties requesting recognition of pharmacotherapy as a specialty. The American College of Clinical Pharmacy. American Pharmacy 28(5): 44-50
Van der Lugt, N.; Maandag, E.R.; te Riele, H.; Laird, P.W.; Berns, A. 1991: A pgk::hprt fusion as a selectable marker for targeting of genes in mouse embryonic stem cells: disruption of the T-cell receptor delta-chain-encoding gene. Gene 105(2): 263-267
Windle, B.E.; Hays, J.B. 1986: A phage P1 function that stimulates homologous recombination of the Escherichia coli chromosome. Proceedings of the National Academy of Sciences of the United States of America 83(11): 3885-3889
Scott, J.R.; Laping, J.L.; Chesney, R.H. 1977: A phage P1 virulent mutation at a new map location. Virology 78(1): 346-348
Anderson, J.E.; Ptashne, M.; Harrison, S.C. 1985: A phage repressor-operator complex at 7 A resolution. Nature 316(6029): 596-601
Feo, S.; Davies, B.; Fried, M. 1990: A phage screening method to isolate intron-containing genes in the presence of multiple processed pseudogenes. Nucleic Acids Research 18(16): 4949-4950
Ward, L.R.; de Sa, J.D.; Rowe, B. 1987: A phage-typing scheme for Salmonella enteritidis. Epidemiology and Infection 99(2): 291-294
Waye, M.M.; Mui, F.; Hodge, K.; Li, V.K. 1991: A phagemid vector library for cloning DNA with four-nucleotide 5' or 3' overhangs. Plasmid 26(1): 74-77
Gigli, I.; Wintroub, B.U.; Goetzl, E.J. 1976: A phagocytosis-enhancing factor in human plasma. Immunology 30(6): 915-924
Riley, C.B.; Yovich, J.V.; Huxtable, C.R. 1990: A phalangeal fusion defect and osteochondrosis dissecans with subluxation of the distal interphalangeal joints in a foal. Australian Veterinary Journal 67(9): 331-333
Oosterbosch, J.; De Smet, L.; Fabry, G.; Van Damme, B. 1992: A phalangeal osteoid osteoma. Case report. Acta Orthopaedica Belgica 58(4): 465-467
Griffiths, H. 1988: A phantom for electrical impedance tomography. Clinical Physics and Physiological Measurement: An Official Journal of the Hospital Physicists' Association Deutsche Gesellschaft für Medizinische Physik and the European Federation of Organisations for Medical Physics 9 Suppl A: 15-20
Hudson, F.R.; Davis, J.B.; Mott, G.T. 1977: A phantom for simulating fast dynamic studies on a gamma camera. Physics in Medicine and Biology 22(1): 87-89
Thompson, S.R.; Faulkner, K. 1991: A phantom for the measurement of contrast detail performance in film-screen mammography. British Journal of Radiology 64(767): 1049-1055
Weisstein, N.; Maguire, W.; Berbaum, K. 1977: A phantom-motion aftereffect. Science 198(4320): 955-958
Sullivan, J.W. 1990: A pharmaceutical manufacturer's perspective on reporting adverse drug experiences. American Journal of Hospital Pharmacy 47(6): 1342-1345
Elzarian, E.J. 1975: A pharmaceutical perspective of Australia's Health Benefits Program. Journal of the American Pharmaceutical Association 15(12): 695-8 708
Burrus, O. 1985: A pharmacist at the bedside? to do what?. Revue de l'Infirmiere 35(8): 41-45
Smolenski, S.J. 1979: A pharmacist in a clinical environment. Materia Medica Polona. Polish Journal of Medicine and Pharmacy 11(2): 185-187
Coffey, D.G. 1992: A pharmacist in the future?. American Journal of Hospital Pharmacy 49(8): 1911-1912
Kradjan, W.A. 1976: A pharmacist's experience in a teaching program for patients on anticoagulant medication. Hospital Pharmacy 11(7): 257-8 262-4 270
Uretsky, S.D. 1985: A pharmacist's guide to quack weight products. American Pharmacy 25(2): 24-29
Sullivan, M.J. 1976: A pharmacist's perception of quality. Journal of the American Pharmaceutical Association 16(11): 609-611
Norman, E.B. 1979: A pharmacist's personal experiences with generic drugs. Missouri Medicine 76(3): 127-128
Tschampel, M.M. 1987: A pharmacist's point of view. Journal of Enterostomal Therapy 14(1): 45
Yajima, C.; Sugai, N.; Hanaoka, K.; Numata, K. 1990: A pharmacodynamic analysis of the onset of neuromuscular blockade by nondepolarizing muscle relaxants--the pharmacodynamics of a large dose of vecuronium. Masui. Japanese Journal of Anesthesiology 39(1): 2-7
Chen, J.K.; Song, S.; Yang, P.J.; He, M.L.; Fan, S.B.; Li, L.M.; Gui, Y.L.; Fotherby, K. 1990: A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill. Contraception 42(4): 439-453
Anderson, R.E.; Cragun, J.M.; Chang, R.J.; Stanczyk, F.Z.; Lobo, R.A. 1989: A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome. Fertility and Sterility 52(2): 216-220
Hriscu, A.; Stănescu, U.; Ionescu, A.; Verbuţă, A. 1990: A pharmacodynamic investigation of the effect of polyholozidic substances extracted from Plantago sp. on the digestive tract. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 94(1): 165-170
Maxwell, D.M.; Vlahacos, C.P.; Lenz, D.E. 1988: A pharmacodynamic model for soman in the rat. Toxicology Letters 43(1-3): 175-188
Praefort, L. 1990: A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children. Cahiers d'Anesthesiologie 38(2): 79-85
Reyes, E.; Jones, B.C. 1985: A pharmacogenetic analysis of the effects of tetrahydrocannabinol (delta 9THC) on brain gamma glutamyl transpeptidase. Neurobehavioral Toxicology and Teratology 7(2): 167-169
Evans, D.A. 1987: A pharmacogenetic approach to alcoholism. Progress in Clinical and Biological Research 241: 319-322
Rezácová, A.; Spilková, J.; Hubík, J. 1978: A pharmacognostic study of the species Ononis arvensis L. Ceskoslovenska Farmacie 27(10): 452-455
Yuan, C.; Li, L.; Ding, Z.; Zhou, Y. 1990: A pharmacognostical study on the fruits of Cnidium monnieri (L.) Cuss. Zhongguo Zhong Yao Za Zhi 15(11): 649
Hiramatsu, M.; DiStefano, E.; Chang, A.S.; Cho, A.K. 1991: A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates. European Journal of Pharmacology 204(2): 135-140
Meltzer, H.L. 1991: A pharmacokinetic analysis of long-term administration of rubidium chloride. Journal of Clinical Pharmacology 31(2): 179-184
Weisel, M.K.; Powers, J.D.; Powers, T.E.; Baggot, J.D. 1977: A pharmacokinetic analysis of tylosin in the normal dog. American Journal of Veterinary Research 38(2): 273-275
Schwendener, R.A.; Wüthrich, R.; Duewell, S.; Wehrli, E.; von Schulthess, G.K. 1990: A pharmacokinetic and MRi study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. Investigative Radiology 25(8): 922-932
Fujii, R.; Hashira, S.; Arimasu, O.; Fujita, K.; Murono, K.; Sakata, H.; Kakehashi, H.; Oka, T.; Kaeriyama, M.; Yoshioka, H. 1986: A pharmacokinetic and clinical evaluation of ceftazidime in neonates and premature infants. a study of ceftazidime in the perinatal co-research group. Japanese Journal of Antibiotics 39(8): 2048-2067
Ankier, S.I.; Warrington, S.J.; Sneddon, J.M. 1991: A pharmacokinetic and dynamic study of single nightly doses of conventional and controlled release formulations of trazodone. Methods and Findings in Experimental and Clinical Pharmacology 13(2): 121-127
Cedarbaum, J.M.; Kutt, H.; McDowell, F.H. 1989: A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100). Neurology 39(11 Suppl 2: 38-44; Discussion 59
Oosterhuis, B.; Jonkman, J.; Zuiderwijk, P.; Sollie, F. 1990: A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation. Journal of Clinical Pharmacology 30(S2): S33-S38
Dahlström, B.; Paalzow, G.; Paalzow, L. 1975: A pharmacokinetic approach to morphine analgesia and its relation to regional turnover of rat brain catecholamines. Life Sciences 17(1): 11-16
Stapleton, J.V.; Austin, K.L.; Mather, L.E. 1979: A pharmacokinetic approach to postoperative pain: continuous infusion of pethidine. Anaesthesia and Intensive Care 7(1): 25-32
Wellner, U. 1989: A pharmacokinetic approach to studying the uptake of 137Cs by children following the reactor accident at Chernobyl. Nuklearmedizin. Nuclear Medicine 28(6): 243-246
Mallinger, A.G.; Poust, R.I.; Mallinger, J.; Himmelhoch, J.M.; Neil, J.F.; Koo, E.; Hanin, I. 1985: A pharmacokinetic approach to the study of cell membrane lithium transport in vivo. Journal of Clinical Psychopharmacology 5(2): 78-82
Brune, K.; Graf, P.; Rainsford, K.D. 1977: A pharmacokinetic approach to the understanding of therapeutic effects and side effects of salicylates. Agents and Actions. Supplements 1: 9-26
Cohen, R.M. 1985: A pharmacokinetic approach to the use of theophylline in status asthmaticus. Annals of Allergy 54(1): 1-11
Firsov, A.A.; Sudilovskaia, N.N.; Strachunskiĭ, L.S. 1991: A pharmacokinetic basis for schedules for administering amikacin to newborn infants. Pediatriia 8: 33-38
Schulman, M.D.; Valentino, D.; Cifelli, S.; Lang, R.; Ostlind, D.A. 1979: A pharmacokinetic basis for the efficacy of 4-amino-6-trichloroethenyl-1,3,-benzenedisulfonamide against Fasciola hepatica in the rat. Journal of Parasitology 65(4): 555-561
Van Boven, M.; Roelandts, R.; De Greef, H.; Kinget, R.; Adriaens, P.; Daenens, P. 1985: A pharmacokinetic comparison in dogs of seven brands of 8-MOP and five new formulations. Photo-Dermatology 2(1): 27-31
Welling, P.G.; Selen, A.; Pearson, J.G.; Kwok, F.; Rogge, M.C.; Ifan, A.; Marrero, D.; Craig, W.A.; Johnson, C.A. 1985: A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures. Biopharmaceutics and Drug Disposition 6(2): 147-157
Ryley, N.J.; Lingam, G. 1988: A pharmacokinetic comparison of controlled-release and standard naproxen tablets. Current Medical Research and Opinion 11(1): 10-15
Hore, P.; Bones, P.; Rollinson, T.; Ikram, H. 1979: A pharmacokinetic comparison of two sustained-release oral procainamide preparations. British Journal of Clinical Pharmacology 8(3): 267-271
Hebenstreit, G.F.; Fellerer, K.; Zöchling, R.; Zentz, A.; Dunbar, G.C. 1989: A pharmacokinetic dose titration study in adult and elderly depressed patients. Acta Psychiatrica Scandinavica. Supplementum 350: 81-84
Phillips, J.P.; Antal, E.J.; Smith, R.B. 1986: A pharmacokinetic drug interaction between erythromycin and triazolam. Journal of Clinical Psychopharmacology 6(5): 297-299
Davy, M.; Paus, E.; Lehne, G. 1985: A pharmacokinetic evaluation of IM administration of bleomycin oil suspension. Cancer ChemoTherapy and Pharmacology 14(3): 274-276
Norris, R.J.; Lee, E.H.; Muirhead, D.; Sanders, S.W. 1986: A pharmacokinetic evaluation of celiprolol in healthy elderly volunteers. Journal of Cardiovascular Pharmacology 8(Suppl 4): S91-S92
Kummen, M.; Lie, K.K.; Lie, S.O. 1978: A pharmacokinetic evaluation of free and DNA-complexed adriamycin: a preliminary study in children with malignant disease. Acta Pharmacologica et Toxicologica 42(3): 212-218
Smith, D.; Aldrich, W.; Dey, M.; Enever, R.; Warner, R.; Weierstall, R. 1990: A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(4): 429-434
Ramu, A.; Fusner, J.E. 1979: A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection. Israel Journal of Medical Sciences 15(6): 494-499
Ferry, J.J.; Wagner, J.G. 1985: A pharmacokinetic model for prednisone after infusion to steady-state in the rabbit. Biopharmaceutics and Drug Disposition 6(3): 335-339
Ogiso, T.; Ito, Y.; Iwaki, M.; Atago, H. 1989: A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics. Journal of Pharmaceutical Sciences 78(4): 319-323
Li, X.Q.; Donovan, C.A.; Klein, L. 1989: A pharmacokinetic model in the rat and rabbit of the direct measurement of mature bone resorption in vivo with [3H]tetracycline. Journal of Pharmaceutical Sciences 78(10): 823-828
Colburn, W.A. 1979: A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism. Journal of Pharmacokinetics and Biopharmaceutics 7(4): 407-415
Sato, A.; Nakajima, T.; Fujiwara, Y.; Murayama, N. 1977: A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. British Journal of Industrial Medicine 34(1): 56-63
Korth-Bradley, J.M. 1991: A pharmacokinetic primer for intravenous nurses. Journal of Intravenous Nursing: the Official Publication of the Intravenous Nurses Society 14(1): 16-27
Callaghan, J.T.; Bergstrom, R.F.; Rubin, A.; Chernish, S.; Crabtree, R.; Knadler, M.P.; Obermeyer, B.; Offen, W.W.; Schneck, D.W.; Aronoff, G. 1987: A pharmacokinetic profile of nizatidine in man. Scandinavian Journal of Gastroenterology. Suppl 136: 9-17
Nanri, S.; Sunakawa, K.; Yamashita, N.; Akita, H.; Hotta, M.; Jozaki, K.; Iwata, S.; Iwasaki, Y.; Kanemitsu, T.; Tojo, M. 1987: A pharmacokinetic study in (mature and premature) neonates treated with amikacin through intravenous drip infusion. Japanese Journal of Antibiotics 40(6): 1135-1145
Oustrin, J.; Fauran, M.J.; Commanay, L. 1977: A pharmacokinetic study of 3H-diosmine. Arzneimittel-Forschung 27(9): 1688-1691
Martinez, L.; Basi, N.; Dordal, A.; Roser, R.; Sagarra, R. 1991: A pharmacokinetic study of E-4441, a new quinolone, in the rat, mouse and cynomolgus monkey. European Journal of Drug Metabolism and Pharmacokinetics (Special Issue 3): 352-356
Eksborg, S.; Andersson, M.; Domellöf, L.; Lönroth, U. 1986: A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration. Medical Oncology and Tumor PharmacoTherapy 3(2): 105-110
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients. Transplantation Proceedings 19(5): 4063-4065
Sorri, M.; Jokinen, K.; Peltomäki, E. 1979: A pharmacokinetic study of bacampicillin in patients with chronic maxillary sinusitis. Infection 7(Suppl 5): S475-S477
Louis, W.J.; McNeil, J.J.; Workman, B.S.; Drummer, O.H.; Conway, E.L. 1987: A pharmacokinetic study of carvedilol (BM 14.190) in elderly subjects: preliminary report. Journal of Cardiovascular Pharmacology 10 Suppl. 11: S89-S93
Billebaud, T.; Astier, L.; Rutkowski, A.; Boccon-Gibod, L. 1990: A pharmacokinetic study of diffusion in adenomatous prostatic tissue of an intravenous bolus of cefamandole. Annales d'Urologie 24(2): 141-145
Ueno, Y.; Fukunaga, T.; Mizoi, Y.; Adachi, J.; Fujiwara, S. 1990: A pharmacokinetic study of ethanol elimination--first pass metabolism and elimination rate. Arukoru Kenkyu to Yakubutsu Izon 25(2): 103-115
Carmichael, J.; Cantwell, B.M.; Edwards, C.M.; Zussman, B.D.; Thompson, S.; Rapeport, W.G.; Harris, A.L. 1989: A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer ChemoTherapy and Pharmacology 24(1): 45-49
Dominici, C.; Petrucci, F.; Caroli, S.; Alimonti, A.; Clerico, A.; Castello, M.A. 1989: A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(1): 100-107
Hardy, F.; Warrington, P.S.; MacPherson, J.S.; Hudson, S.A.; Jefferson, G.C.; Smyth, J.F. 1990: A pharmacokinetic study of high-dose metoclopramide suppositories. Journal of Clinical Pharmacy and Therapeutics 15(1): 21-24
Fujita, H.; Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1992: A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 791-798
Umekita, N.; Awane, Y.; Maeshiro, T.; Miyamoto, S.; Yamada, F.; Matsumine, T. 1992: A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1544-1546
Young, J.F.; Haley, T.J. 1978: A pharmacokinetic study of pentachlorophenol poisoning and the effect of forced diuresis. Clinical Toxicology 12(1): 41-48
Lameire, N.; Rosenkranz, B.; Maass, L.; Brockmeier, D. 1988: A pharmacokinetic study of roxatidine acetate in chronic renal failure. Drugs 35(Suppl 3): 48-52
Messiha, F.S.; Larson, J.W. 1976: A pharmacokinetic study of rubidium and cesium salts. Proceedings of the Western Pharmacology Society 19: 108-112
Minagawa, K.; Mizuno, S.; Shirai, H.; Miura, H. 1985: A pharmacokinetic study on the effectiveness of intermittent oral diazepam in the prevention of recurrent febrile convulsions. No to Hattatsu 17(2): 162-167
Nomura, M. 1988: A pharmacokinetic study on the tissue distribution of pyridonecarboxylic acids. Hiroshima Daigaku Shigaku Zasshi. Journal of Hiroshima University Dental Society 20(2): 256-272
Benjamin, R.S.; Hall, S.W.; Burgess, M.A.; Wheeler, W.L.; Murphy, W.K.; Blumenschein, G.R.; Gottlieb, J.A. 1976: A pharmacokinetically based phase I-Ii study of single-dose actinomycin D (NSC-3053). Cancer Treatment Reports 60(3): 289-291
Arefolov, V.A.; Pidevich, I.N.; Panasiuk, L.V.; Firsov, V.K. 1975: A pharmacologic analysis of several adrenomimetic effects of serotonin. Biulleten' Eksperimental'noi Biologii i Meditsiny 80(11): 45-48
Gusel'nikova, K.G.; Ivanova, L.V.; Kipor, G.V. 1975: A pharmacologic analysis of the slow potential arising in response to adequate stimulation of the frog olfactory bulb. Neirofiziologiia 7(4): 372-379
Caritis, S.N. 1988: A pharmacologic approach to the infusion of ritodrine. American Journal of Obstetrics and Gynecology 158(2): 380-384
Levin, V.A. 1975: A pharmacologic basis for brain tumor chemotherapy. Seminars in Oncology 2(1): 57-61
Nozaki, M.; Vaupel, D.B.; Martin, W.R. 1977: A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog. European Journal of Pharmacology 46(4): 339-349
Edvinsson, L.; Owman, C. 1975: A pharmacologic comparison of histamine receptors in isolated extracranial and intracranial arteries in vitro. Neurology 25(3): 271-276
Del Pizzo, A. 1975: A pharmacologic evaluation of local anesthesia. Aana Journal 43(4): 375-393
Buckner, C.K.; Dea, D.; Liberati, N.; Krell, R.D. 1991: A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig. Journal of Pharmacology and Experimental Therapeutics 257(1): 26-34
Andersen, J.B.; Jensen, N.H.; Klausen, N.O. 1989: A pharmacologic respiratory stimulant, doxapram, used in acute deterioration in patients with chronic respiratory failure. Ugeskrift for Laeger 151(28): 1820-1822
Schmidt, R.T.; Stahl, S.M.; Spehlmann, R. 1975: A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion. Neurology 25(7): 622-626
Felt, D.P.; Frueh, B.R. 1988: A pharmacologic study of the sympathetic eyelid tarsal muscles. Ophthalmic Plastic and Reconstructive Surgery 4(1): 15-24
Roozekrans, N.T.; Van Zwieten, P.A. 1977: A pharmacological analysis of Cushing's response in rats. Progress in Brain Research 47: 425-428
Loizzo, A.; Caroli, S.; De Maria, G.; Ortolani, E. 1986: A pharmacological analysis of aluminium effects on the central nervous system. Annali Dell'istituto Superiore di Sanita 22(2): 703-708
Dawson, R.; Wallace, D.R.; Gabriel, S.M. 1989: A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacology Biochemistry and Behavior 32(2): 391-398
Middlemiss, D.N.; Bremer, M.E.; Smith, S.M. 1988: A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex. European Journal of Pharmacology 157(1): 101-107
Trepakov, V.V.; Saakian, S.A. 1991: A pharmacological analysis of the GABA-ergic system of the primordial hippocampus in the frog Rana temporaria. Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki 9: 82-86
Wood, C.M. 1975: A pharmacological analysis of the adrenergic and cholinergic mechanisms regulating branchial vascular resistance in the rainbow trout (Salmo gairdneri). Canadian Journal of Zoology 53(11): 1569-1577
Talalaenko, A.N. 1989: A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction. Farmakologiia i Toksikologiia 52(6): 26-29
Karkishchenko, N.N.; Khaĭtin, M.I.; Simkina, I.N. 1991: A pharmacological analysis of the anxiolytic activity of uridine. Farmakologiia i Toksikologiia 54(1): 16-18
Bul'on, V.V.; Khnychenko, L.K. 1990: A pharmacological analysis of the central monoaminergic mechanisms of the development of neurogenic stomach damage. Farmakologiia i Toksikologiia 53(2): 36-38
Khegaĭ, M.D. 1990: A pharmacological analysis of the cholinergic system in animals with alloxan diabetes. Farmakologiia i Toksikologiia 53(4): 42-43
Kamien, J.B.; Woolverton, W.L. 1989: A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 248(3): 938-946
Fletcher, P.J.; Davies, M. 1990: A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism. Psychopharmacology 100(2): 188-194
Gillespie, J.S.; Khoyl, M.A. 1975: A pharmacological analysis of the inhibitory effects of the sympathetic nerves on the rabbit colon. Journal of Physiology 244(1): 42P-43P
Toreva, D.; Lukanov, I.; Kostadinova, I.; Zaprianov, G.; Krŭstev, A. 1991: A pharmacological analysis of the mechanism of action of ethosuximide. Farmakologiia i Toksikologiia 54(1): 23-27
Tonini, M.; Costa, M. 1990: A pharmacological analysis of the neuronal circuitry involved in distension-evoked enteric excitatory reflex. Neuroscience 38(3): 787-795
Hall, E.D.; Wolf, D.L. 1986: A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. Journal of Neurosurgery 64(6): 951-961
Brown, L.; Amedro, J.; Williams, G.; Smith, D. 1988: A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor. European Journal of Pharmacology 145(2): 163-171
Novikov, V.E.; Iasnetsov, V.V.; Sharov, A.N. 1992: A pharmacological analysis of the role of GABA- and opioidergic systems in the development of brain edema. Biulleten' Eksperimental'noi Biologii i Meditsiny 114(8): 163-165
Ammannati, P.; Siravo, D.; Conte, B. 1989: A pharmacological and clinical review on the activity of a bovine factor VIIi derivative obtained by enzymatic hydrolysis. La Clinica Terapeutica 128(4): 271-290
Takagi, T.; Forrest, M.J.; Brooks, P.M. 1987: A pharmacological and histological examination of the microcirculation of the rat subcutaneous air-pouch: microcirculation of the rat air-pouch. Pathology 19(3): 294-298
Kiernan, J.A. 1975: A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 60(2): 123-130
Osborne, P.; Campbell, G. 1986: A pharmacological and immunohistochemical study of the splanchnic innervation of ileal longitudinal muscle in the toad Bufo marinus. Naunyn-Schmiedeberg's Archives of Pharmacology 334(2): 210-217
Mózsik, G.; Garamszegi, M.; Jávor, T.; Nagy, L.; Sütö, G.; Vincze, A. 1989: A pharmacological approach to cellular mechanisms of PGI2-induced gastric cytoprotection on ethanol-induced gastric mucosal damage in rats. Acta Physiologica Hungarica 73(2-3): 207-211
Szolcsányi, J. 1977: A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. Journal de Physiologie 73(3): 251-259
Ritchie, J.M. 1979: A pharmacological approach to the structure of sodium channels in myelinated axons. Annual Review of Neuroscience 2: 341-362
Kehl, S.J.; McLennan, H. 1985: A pharmacological characterization of chloride- and potassium-dependent inhibitions in the CA3 region of the rat hippocampus in vitro. Experimental Brain Research 60(2): 309-317
Nozaki, M.; Vaupel, D.B.; Bright, L.D.; Martin, W.R. 1978: A pharmacological comparison of 3-methoxy-4,5-methylenedioxyamphetamine and LSD in the dog. Drug and Alcohol Dependence 3(3): 153-163
Sharif, N.A.; Nunes, J.L.; Kalfayan, V.; McClelland, D.L.; Rosenkranz, R.P.; Eglen, R.M.; Whiting, R.L. 1992: A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?. Neurochemistry International 21(1): 69-73
Waxman, J.; Sandow, J.; Thomas, H.; James, N.; Williams, G. 1989: A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer. Cancer ChemoTherapy and Pharmacology 25(3): 219-220
Cohen, S.L. 1986: A pharmacological examination of the resistance-to-change hypothesis of response strength. Journal of the Experimental Analysis of Behavior 46(3): 363-379
Frank, G.B. 1986: A pharmacological explanation of the use-dependency of the verapamil (and D-600) block of slow calcium channels. Journal of Pharmacology and Experimental Therapeutics 236(2): 505-511
Solanki, K.K.; Bomanji, J.; Moyes, J.; Mather, S.J.; Trainer, P.J.; Britton, K.E. 1992: A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nuclear Medicine Communications 13(7): 513-521
Morgan, R.; Sillito, A.M.; Wolstencroft, J.H. 1975: A pharmacological investigation of inhibition in the lateral geniculate nucleus. Journal of Physiology 246(2): 93P-94P
Bury, R.W.; Mashford, M.L. 1977: A pharmacological investigation of synthetic substance P on the isolated guinea-pig ileum. Clinical and Experimental Pharmacology and Physiology 4(5): 453-461
Angel, A.; Dewhurst, D.G. 1978: A pharmacological investigation of the electrically evoked convulsive activity induced by administration of catechol in the anaesthetized rat. British Journal of Pharmacology 64(4): 539-544
Dagani, F.; Ferrari, R.; Canevari, L. 1990: A pharmacological model for studying the role of Na+ gradients in the modulation of synaptosomal free [Ca2+]i levels and energy metabolism. Brain Research 530(2): 261-266
Klawans, H.L.; Westheimer, R.; Goetz, C.C. 1975: A pharmacological model of the pathophysioloyg of schizophrenia. Diseases of the Nervous System 36(5): 267-275
Takenaka, F.; Nishi, K.; Sakanashi, M. 1975: A pharmacological of sympathetic afferent discharges originating from the cardiac region. Proceedings of the Western Pharmacology Society 18: 1-4
Gillman, M.A.; Lichtigfeld, F.J. 1985: A pharmacological overview of opioid mechanisms mediating analgesia and hyperalgesia. Neurological Research 7(3): 106-119
Hindmarch, I. 1988: A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. British Journal of Psychiatry. Supplement 3: 99-104
Gray, D.W.; Marshall, I. 1992: A pharmacological profile of the endothelium-derived relaxant factor released by calcitonin gene-related peptide in rat aorta. Annals of the New York Academy of Sciences 657: 517-518
Kendall, M.J.; Wise, R.; Andrews, J.M.; Bedford, K.A. 1978: A pharmacological study of UK-18,892 and amikacin. Journal of Antimicrobial ChemoTherapy 4(5): 459-463
Curtis, D.R.; Gynther, B.D.; Malik, R. 1986: A pharmacological study of group I muscle afferent terminals and synaptic excitation in the intermediate nucleus and Clarke's column of the cat spinal cord. Experimental Brain Research 64(1): 105-113
Christensen, J.; Percy, W.H. 1985: A pharmacological study of oesophageal muscularis mucosae from the cat, dog and American opossum (Didelphis virginiana). Addendum. British Journal of Pharmacology 85(2): 565
Misra, V.; Singh, K.N.; Bapat, S.K. 1977: A pharmacological study of the effect of adrenaline, noradrenaline and acetylcholine on kidneys. Indian Journal of Physiology and Pharmacology 21(1): 45-49
Kenawy, S.A.; Lewis, G.P. 1979: A pharmacological study of the mediators released following anaphylaxis of the sensitised hind quarters of the guinea-pig. British Journal of Pharmacology 66(1): 143P-144P
Imai, Y. 1990: A pharmacological study of the participation of the peripheral endings of primary afferent neurons in the inflammatory response evoked by heat and mechanical noxious stimulation. Journal of Osaka University Dental Society 35(1): 307-320
Roberts, K.E.; Newberry, N.R. 1990: A pharmacological study of the responses induced by muscarinic agonists on the isolated superior cervical ganglion of the guinea-pig. European Journal of Pharmacology 186(2-3): 257-265
Angel, A.; Clarke, K.A.; Dewhurst, D.G. 1977: A pharmacological study of the spontaneous convulsive activity induced by 1,2-dihydroxybenzene (catechol) in the anaesthetized mouse. British Journal of Pharmacology 61(3): 433-439
Kato, T.; Yamawaki, S. 1989: A pharmacological study of veratrine-induced hyperthermia in the rat: a model of neuroleptic malignant syndrome. Hiroshima Journal of Medical Sciences 38(4): 173-181
Murakoshi, T.; Suzue, T.; Tamai, S. 1985: A pharmacological study on respiratory rhythm in the isolated brainstem-spinal cord preparation of the newborn rat. British Journal of Pharmacology 86(1): 95-104
Kojo, T. 1991: A pharmacological study on the mechanism of the endothelin-induced contraction of the bovine cerebral artery. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 53(3): 87-97
Baysal, F.; Vural, H. 1976: A pharmacological study on the possible nature of the cholinergic receptor of the frog ventricles. Turk Hijiyen Ve Deneysel Biyoloji Dergisi. Turkish Bulletin of Hygiene and Experimental Biology 36(1): 45-51
Pautler, E.L.; Maga, J.A.; Tengerdy, C. 1986: A pharmacologically potent natural product in the bovine retina. Experimental Eye Research 42(3): 285-288
Bárány, E.H. 1979: A pharmacologist looks at medical treatment in glaucoma--in retrospect and in prospect. Ophthalmology 86(1): 80-94
Erickson, C.K. 1992: A pharmacologist's opinion--alcoholism: the disease debate needs to stop. Alcohol and Alcoholism 27(4): 325-328
Wang, J.X. 1988: A pharmacopoeia compiled on the order of the Emperor Song Taizong. Journal of Traditional Chinese Medicine 8(3): 232-233
Triscari, J.; Sullivan, A.C. 1987: A pharmacotherapeutic approach to the regulation of hyperinsulinemia and obesity. International Journal of Obesity 11(Suppl 3): 43-51
Messiha, F.S. 1979: A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette's syndrome. Proceedings of the Western Pharmacology Society 22: 27-29
Honorato, J.; Rubio, A.; Tristán, C.; Otero, F.J.; Garrido, J. 1990: A pharmacovigilance study with bentazepam in a sample of 1046 psychiatric outpatients. Revista de Medicina de la Universidad de Navarra 34(2): 80-88
Meyer, S.K.; Brittan, J.C.; Destache, C.; Gurnee, M.C.; Barone, E.J. 1986: A pharmacy fellowship in a family practice training program. Family Medicine 18(6): 394-396
Casavant, E.M.; Moleschi, M. 1989: A pharmacy service between community hospitals. Dimensions in Health Service 66(8): 31-32
Riddiough, M.A. 1979: A pharmacy service is not a pharmacy service is not a pharmacy service. American Pharmacy 19(8): 8
Trudeau, T.W.; Braden, F.M. 1976: A pharmacy-coordinated year-round poison control program. Journal of the American Pharmaceutical Association 16(12): 664-665
Salazar Barcelona, F.; Infante Sánchez, J.C.; Lacosta Nicolás, J.L.; Molla Rudiez, J.; Elordi Zamalloa, P. 1991: A pharyngolaryngeal cancer study in the Autonomous Community of la Rioja. Acta Otorrinolaringologica Espanola 42(3): 164-168
Zonnenberg, B.A.; von Dijk, A.; Vendrik, C.P.; Schornagel, J.H.; Struyvenberg, A. 1990: A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554). Cancer ChemoTherapy and Pharmacology 25(4): 279-285
Roberts, R.B.; Jurica, K.; Meyer, W.A.; Paxton, H.; Makuch, R.W. 1990: A phase 1 study of ribavirin in human immunodeficiency virus-infected patients. Journal of Infectious Diseases 162(3): 638-642
Hu, E.; Epstein, A.L.; Naeve, G.S.; Gill, I.; Martin, S.; Sherrod, A.; Nichols, P.; Chen, D.; Mazumder, A.; Levine, A.M. 1989: A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies. Hematological Oncology 7(2): 155-166
Sawaki, S. 1990: A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer. Gan no Rinsho. Japan Journal of Cancer Clinics 36(2): 111-120
Reid, I.; Sharpe, I.; Maxwell, W.; McDevitt, J.; Franks, C.R.; Tanner, W.A.; Monson, J.R. 1992: A phase 2 trial of recombinant interleukin-2 and 5-fluorouracil in patients with metastatic colorectal carcinoma. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 18(6): 591-598
Weiss, G.R.; Hersh, M.; Kuhn, J.G.; Ludden, T.M.; von Hoff, D.D.; Kisner, D.L.; Pirtle, T.E. 1985: A phase i and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer. Cancer ChemoTherapy and Pharmacology 15(2): 144-148
Olver, I.N.; Webster, L.K.; Bishop, J.F.; Stokes, K.H. 1992: A phase i and pharmacokinetic study of 12-h infusion of flavone acetic acid. Cancer ChemoTherapy and Pharmacology 29(5): 354-360
Taylor, C.W.; Salmon, S.E.; Satterlee, W.G.; Robertone, A.B.; McCloskey, T.M.; Holdsworth, M.T.; Plezia, P.M.; Alberts, D.S. 1990: A phase i and pharmacokinetic study of intravenous vinzolidine. Investigational new Drugs 8(Suppl 1): S51-S57
De Vries, E.G.; Greidanus, J.; Mulder, N.H.; Nieweg, M.B.; Postmus, P.E.; Schipper, D.L.; Sleijfer, D.T.; Uges, D.R.; Willemse, P.H. 1987: A phase i and pharmacokinetic study with 21-day continuous infusion of epirubicin. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(9): 1445-1451
Eccles, D.M.; Cummings, J.; Stewart, M.E.; Nicolson, M.; Cornbleet, M.A.; Leonard, R.C.; Smyth, J.F. 1992: A phase i and pharmacology study of GR63178A, a water-soluble analogue of mitoquidone. Cancer ChemoTherapy and Pharmacology 29(5): 375-378
Lokich, J.J.; Curt, G. 1985: A phase i and pharmacology study of continuous-infusion low-dose methotrexate administration. Cancer 56(10): 2391-2394
Bork, E.; Vest, S.; Hansen, H.H. 1989: A phase i clinical and pharmacokinetic study of Brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule. European Journal of Cancer and Clinical Oncology 25(10): 1403-1411
Wall, J.G.; Burris, H.A.; Von Hoff, D.D.; Rodriguez, G.; Kneuper-Hall, R.; Shaffer, D.; O'Rourke, T.; Brown, T.; Weiss, G.; Clark, G. 1992: A phase i clinical and pharmacokinetic study of the topoisomerase i inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. Anti-Cancer Drugs 3(4): 337-345
Weiss, G.R.; Sarosy, G.A.; Shenkenberg, T.D.; Williams, T.; Clendeninn, N.J.; Von Hoff, D.D.; Woolley, J.L.; Liao, S.H.; Blum, M.R. 1989: A phase i clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U). European Journal of Cancer and Clinical Oncology 25(12): 1867-1873
Vibe-Petersen, J.; Bork, E.; Møller, H.; Hansen, H.H. 1987: A phase i clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU). European Journal of Cancer and Clinical Oncology 23(12): 1837-1843
Owen, R.R.; Sells, R.A.; Gilmore, I.T.; New, R.R.; Stringer, R.E. 1992: A phase i clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy. Anti-Cancer Drugs 3(2): 101-107
Ducret, J.P.; Caillé, P.; Sancho Garnier, H.; Amiel, J.L.; Michelson, M.; Hovanessian, A.G.; Youn, J.K.; Lacour, F. 1985: A phase i clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients. Journal of Biological Response Modifiers 4(2): 129-133
Rahman, A.; Treat, J.; Roh, J.K.; Potkul, L.A.; Alvord, W.G.; Forst, D.; Woolley, P.V. 1990: A phase i clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(6): 1093-1100
Santana, V.M.; Mirro, J.; Harwood, F.C.; Cherrie, J.; Schell, M.; Kalwinsky, D.; Blakley, R.L. 1991: A phase i clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(3): 416-422
De Souza, J.M.; Sheth, U.K.; de Oliveira, R.M.; Gomes, A.T.; Cavalcante, E.Q. 1985: A phase i clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. Bulletin of the World Health Organization 63(3): 611-615
Anderson, N.; Lokich, J.; Bern, M.; Wallach, S.; Moore, C.; Williams, D. 1989: A phase i clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation. Cancer 63(2): 233-237
Stewart, J.A.; Low, J.B.; Roberts, J.D.; Blow, A. 1991: A phase i clinical trial of didemnin B. Cancer 68(12): 2550-2554
Kirmani, S.; McVey, L.; Loo, D.; Howell, S.B. 1990: A phase i clinical trial of intraperitoneal thiotepa for refractory ovarian cancer. Gynecologic Oncology 36(3): 331-334
Creagan, E.T.; Kovach, J.S.; Moertel, C.G.; Frytak, S.; Kvols, L.K. 1988: A phase i clinical trial of recombinant human tumor necrosis factor. Cancer 62(12): 2467-2471
Creaven, P.J.; Brenner, D.E.; Cowens, J.W.; Huben, R.P.; Wolf, R.M.; Takita, H.; Arbuck, S.G.; Razack, M.S.; Proefrock, A.D. 1989: A phase i clinical trial of recombinant human tumor necrosis factor given daily for five days. Cancer ChemoTherapy and Pharmacology 23(3): 186-191
Creekmore, S.P.; Harris, J.E.; Ellis, T.M.; Braun, D.P.; Cohen, I.I.; Bhoopalam, N.; Jassak, P.F.; Cahill, M.A.; Canzoneri, C.L.; Fisher, R.I. 1989: A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusions. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(2): 276-284
VanWagoner, M.; O'Toole, M.; Worah, D.; Leese, P.T.; Quay, S.C. 1991: A phase i clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent. Investigative Radiology 26(11): 980-986
Vest, S.; Bork, E.; Hansen, H.H. 1988: A phase i evaluation of N10-propargyl-5,8-dideazafolic acid. European Journal of Cancer and Clinical Oncology 24(2): 201-204
Stevenson, H.C.; Abrams, P.G.; Schoenberger, C.S.; Smalley, R.B.; Herberman, R.B.; Foon, K.A. 1985: A phase i evaluation of poly(I,C)-LC in cancer patients. Journal of Biological Response Modifiers 4(6): 650-655
Calvert, A.H.; Alison, D.L.; Harland, S.J.; Robinson, B.A.; Jackman, A.L.; Jones, T.R.; Newell, D.R.; Siddik, Z.H.; Wiltshaw, E.; McElwain, T.J. 1986: A phase i evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 4(8): 1245-1252
Redfield, R.R.; Birx, D.L.; Ketter, N.; Tramont, E.; Polonis, V.; Davis, C.; Brundage, J.F.; Smith, G.; Johnson, S.; Fowler, A. 1991: A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. New England Journal of Medicine 324(24): 1677-1684
Greidanus, J.; de Vries, E.G.; Mulder, N.H.; Sleijfer, D.T.; Uges, D.R.; Oosterhuis, B.; Willemse, P.H. 1989: A phase i pharmacokinetic study of 21-day continuous infusion mitoxantrone. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(6): 790-797
Ariyoshi, Y.; Wakui, A.; Hasegawa, K.; Niitani, H.; Ogawa, M.; Sakai, Y.; Majima, H.; Furue, H.; Miyake, H.; Taguchi, T. 1992: A phase i study of DWA2114R. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 685-693
Kahn, J.O.; Stites, D.P.; Scillian, J.; Murcar, N.; Stryker, R.; Volberding, P.A.; Naylor, P.H.; Goldstein, A.L.; Sarin, P.S.; Simmon, V.F. 1992: A phase i study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. Aids Research and Human Retroviruses 8(8): 1321-1325
Hertler, A.A.; Schlossman, D.M.; Borowitz, M.J.; Laurent, G.; Jansen, F.K.; Schmidt, C.; Frankel, A.E. 1988: A phase i study of T101-ricin a chain immunotoxin in refractory chronic lymphocytic leukemia. Journal of Biological Response Modifiers 7(1): 97-113
Wakui, A.; Yokoyama, M.; Takahashi, H.; Yoshida, Y.; Sakata, Y.; Sato, S.; Kano, A.; Kawamoto, K.; Hashimoto, S.; Konno, K. 1986: A phase i study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 319-329
Coia, L.; Krigel, R.; Hanks, G.; Comis, R.; Algazy, K.; Peters, R.; McCulloch, W.; Schien, P. 1992: A phase i study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies. International Journal of Radiation Oncology Biology Physics 22(4): 791-794
Bhalla, K.; Birkhofer, M.; Bhalla, M.; Lutzky, J.; Hindenburg, A.; Cole, J.; Ince, C. 1991: A phase i study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer. American Journal of Clinical Oncology 14(6): 509-513
McIntosh, I.H.; Thynne, G.S.; Bejrajati, P.; Walsh, G.; Greening, W.P. 1977: A phase i study of a multi-modal schedule with Corynebacterium parvum. Developments in Biological Standardization 38: 477-482
Falkson, G.; van Zyl, A.J. 1989: A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting. Cancer ChemoTherapy and Pharmacology 24(3): 193-196
Tamura, K.; Makino, S.; Araki, Y. 1990: A phase i study of a new cisplatin derivative for hematologic malignancies. Cancer 66(10): 2059-2063
Huberman, M.; Bering, H.; Fallon, B.; Tessitore, J.; Sonnenborn, H.; Paul, S.; Zeffren, J.; Levitt, D.; Groopman, J. 1991: A phase i study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. Cancer 68(8): 1708-1713
Ogawa, M.; Imajo, K.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Yamazaki, H.; Ueno, K.; Nakamura, T.; Aiba, K.; Kuraishi, Y. 1987: A phase i study of carboplatin. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(5 Part 1): 1292-1296
Kovach, J.S.; Moertel, C.G.; Schutt, A.J.; Frytak, S.; O'Connell, M.J.; Rubin, J.; Ingle, J.N. 1979: A phase i study of chlorozotocin (NSC 178248). Cancer 43(6): 2189-2196
Fukuoka, M.; Masuda, N.; Negoro, S.; Takada, M.; Kudoh, S.; Kusunoki, Y.; Matsui, K.; Takifuji, N.; Tachikawa, A.; Kawahara, M. 1991: A phase i study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer. Cancer 68(2): 284-288
Vokes, E.E.; Ratain, M.J.; Janisch, L.; Hoffman, P.C.; Golomb, H.M.; Schilsky, R.L. 1991: A phase i study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients. European Journal of Cancer 27(2): 217-218
Palmeri, S.; Gebbia, V.; Russo, A.; Gebbia, N.; Rustum, Y.; Rausa, L.; Creaven, P.; Petrelli, N. 1991: A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma. Journal of ChemoTherapy 3(3): 170-175
Frytak, S.; Moertel, C.G.; Schutt, A.J.; Ahmann, D.L.; Donadio, J.V.; Weinshilboum, R.M. 1976: A phase i study of cytembena. Cancer 37(3): 1248-1255
Smit, E.F.; Splinter, T.A.; Kok, T.C. 1992: A phase i study of daily oral teniposide for 20 days. Seminars in Oncology 19(2 Suppl 6: 40-42
Olver, I.N.; Reece, P.A.; Bishop, J.F.; Morris, R.G.; Hillcoat, B.L.; Guentert, T.W. 1990: A phase i study of doxifluridine as a five-day stepped-dose continuous infusion. American Journal of Clinical Oncology 13(4): 308-311
Lipton, A.; Harvey, H.A.; Glenn, J.; Weidner, W.A.; Strauss, M.; Miller, S.E.; Taylor, J.B.; White-Hershey, D.; Barlow, J.L. 1989: A phase i study of hepatic arterial infusion using difluoromethylornithine. Cancer 63(3): 433-437
Elias, A.D.; Ayash, L.J.; Eder, J.P.; Wheeler, C.; Deary, J.; Weissman, L.; Schryber, S.; Hunt, M.; Critchlow, J.; Schnipper, L. 1991: A phase i study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(2): 320-327
Sznol, M.; Mier, J.W.; Sparano, J.; Gaynor, E.R.; Weiss, G.R.; Margolin, K.A.; Bar, M.H.; Hawkins, M.J.; Atkins, M.B.; Dutcher, J.P. 1990: A phase i study of high-dose interleukin-2 in combination with interferon-alpha 2b. Journal of Biological Response Modifiers 9(6): 529-537
Liberati, A.M.; Biscottini, B.; Fizzotti, M.; Schippa, M.; De Angelis, V.; Senatore, M.; Vittori, O.; Teggia, L.; Natali, R.; Palmisano, L. 1989: A phase i study of human natural interferon-beta in cancer patients. Journal of Interferon Research 9(3): 339-348
Lennard, T.W.; Harris, A.L.; Hales, J.; Dickinson, A.; Wolstencroft, R.; Halcrow, P.; Shenton, B.K.; McDonald, M.; Lawrence, G.F.; Taylor, R.M. 1989: A phase i study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). European Journal of Cancer and Clinical Oncology 25(11): 1571-1576
Roper, M.; Smith, M.A.; Sondel, P.M.; Gillespie, A.; Reaman, G.H.; Hammond, G.D.; Levitt, D.; Rosolen, A.; Colamonici, O.R.; Neckers, L.M. 1992: A phase i study of interleukin-2 in children with cancer. American Journal of Pediatric Hematology/Oncology 14(4): 305-311
Nasr, S.; McKolanis, J.; Pais, R.; Findley, H.; Hnath, R.; Waldrep, K.; Ragab, A.H. 1989: A phase i study of interleukin-2 in children with cancer and evaluation of clinical and immunologic status during therapy. a Pediatric Oncology Group Study. Cancer 64(4): 783-788
Kinsella, T.J.; Russo, A.; Mitchell, J.B.; Collins, J.M.; Rowland, J.; Wright, D.; Glatstein, E. 1985: A phase i study of intravenous iododeoxyuridine as a clinical radiosensitizer. International Journal of Radiation Oncology Biology Physics 11(11): 1941-1946
Van der Schelling, G.P.; IJzermans, J.N.; Kok, T.C.; Scheringa, M.; Marquet, R.L.; Splinter, T.A.; Jeekel, J. 1992: A phase i study of local treatment of liver metastases with recombinant tumour necrosis factor. European Journal of Cancer 28a (6-7): 1073-1078
Stuart, N.S.; Crawford, S.M.; Blackledge, G.R.; Newlands, E.S.; Slack, J.; Hoffman, R.; Stevens, M.F. 1989: A phase i study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor. Cancer ChemoTherapy and Pharmacology 23(5): 308-310
Duncan, W.; McLelland, J.; Davey, P.; Jack, W.J.; Arnott, S.J.; Gordon, A.; Kerr, G.R.; Williams, J.R. 1986: A phase i study of mixed (neutron and photon) irradiation using two fractions per day in the treatment of high-grade astrocytomas. British Journal of Radiology 59(701): 441-444
Handgretinger, R.; Baader, P.; Dopfer, R.; Klingebiel, T.; Reuland, P.; Treuner, J.; Reisfeld, R.A.; Niethammer, D. 1992: A phase i study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a. Cancer Immunology Immunotherapy: Cii 35(3): 199-204
Weppelmann, B.; Wheeler, R.H.; Peters, G.E.; Stephens, S.; Spencer, S.A.; Meredith, R.F.; Kim, R.Y.; Salter, M.M. 1991: A phase i study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck. International Journal of Radiation Oncology Biology Physics 20(2): 357-360
Salem, P.A.; Bodey, G.P.; Burgess, M.A.; Murphy, W.K.; Freireich, E.J. 1977: A phase i study of pyrazofurin. Cancer 40(6): 2806-2809
Smith, D.; Wagstaff, J.; Thatcher, N.; Scarffe, H. 1987: A phase i study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion. Cancer ChemoTherapy and Pharmacology 20(4): 327-331
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Mittelman, A.; Huberman, M.; Puccio, C.; Fallon, B.; Tessitore, J.; Savona, S.; Eyre, R.; Gafney, E.; Wick, M.; Skelos, A. 1990: A phase i study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma. Cancer 66(4): 664-669
Taguchi, T. 1986: A phase i study of recombinant human tumor necrosis factor (rHu-TNF: PT-050). the PT-050 Study Group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3491-3497
Takaku, F. 1988: A phase i study of recombinant interleukin 2 (S6820). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(12): 3271-3276
Krigel, R.L.; Padavic-Shaller, K.A.; Rudolph, A.R.; Litwin, S.; Konrad, M.; Bradley, E.C.; Comis, R.L. 1988: A phase i study of recombinant interleukin 2 plus recombinant beta-interferon. Cancer Research 48(13): 3875-3881
Melioli, G.; Sertoli, M.R.; Bruzzone, M.; Nobile, M.T.; Rosso, R.; Percivale, P.L.; Catturich, A.; Badellino, F.; Balletto, N.; Civalleri, D. 1991: A phase i study of recombinant interleukin-2 intraperitoneal infusion in patients with neoplastic ascites: toxic effects and immunologic results. American Journal of Clinical Oncology 14(3): 231-237
Turner, J.H.; Claringbold, P.G.; Hetherington, E.L.; Sorby, P.; Martindale, A.A. 1989: A phase i study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(12): 1926-1931
Newman, H.F.; Bleehen, N.M.; Workman, P. 1986: A phase i study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics. International Journal of Radiation Oncology Biology Physics 12(7): 1113-1116
Newman, H.F.; Bleehen, N.M.; Workman, P. 1986: A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations. British Journal of Radiology 59(700): 423-425
Rifkin, R.M.; Hersh, E.M.; Salmon, S.E. 1988: A phase i study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. Behring Institute Mitteilungen 83: 125-133
Lokich, J.J.; Egorin, M.J.; Cohen, B.E.; Bern, M.M.; Zipoli, T.E.; Moore, C. 1989: A phase i study of thiotepa administered by short-term and protracted continuous intravenous infusion. Cancer 63(1): 46-50
Tominaga, T.; Abe, O.; Izuo, M.; Nomura, Y. 1990: A phase i study of toremifene. Breast Cancer Research and Treatment 16 Suppl: S27-S29
Bishop, J.F.; Raghavan, D.; Olver, I.N.; Reece, P.; Morris, R.; Friedlander, M.L. 1989: A phase i study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion. Cancer ChemoTherapy and Pharmacology 24(4): 246-250
Jolivet, J.; Landry, L.; Pinard, M.F.; McCormack, J.J.; Tong, W.P.; Eisenhauer, E. 1987: A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections. Cancer ChemoTherapy and Pharmacology 20(2): 169-172
Ceulemans, F.; Humblet, Y.; Bosly, A.; Symann, M.; Trouet, A. 1986: A phase i study of vinblastine tryptophan ester. Cancer ChemoTherapy and Pharmacology 18(1): 44-46
Fukuoka, M.; Negoro, S.; Niitani, H.; Furue, H.; Hasegawa, K.; Hara, Y.; Hara, N.; Taguchi, T. 1990: A phase i study of weekly administration of CPT-11 in lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(5): 993-997
Niitani, H.; Fukuoka, M.; Furusawa, M.; Tamura, M.; Hasegawa, K.; Kurita, Y.; Ariyoshi, Y.; Matsunaga, T.; Kumoi, T.; Kimura, I. 1992: A phase i study on a weekly schedule of DWA2114R. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(7): 1027-1032
Scheinberg, D.A.; Straus, D.J.; Yeh, S.D.; Divgi, C.; Garin-Chesa, P.; Graham, M.; Pentlow, K.; Coit, D.; Oettgen, H.F.; Old, L.J. 1990: A phase i toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(5): 792-803
Kreisle, W.H.; Alberts, D.S.; List, A.F.; McCloskey, T.; Plezia, P.; Peng, Y.M.; George, M. 1991: A phase i trial of 14-day continuous intravenous infusion mitoxantrone. Anti-Cancer Drugs 2(3): 251-259
Deprés-Brummer, P.; Levi, F.; Di Palma, M.; Beliard, A.; Lebon, P.; Marion, S.; Jasmin, C.; Misset, J.L. 1991: A phase i trial of 21-day continuous venous infusion of alpha-interferon at circadian rhythm modulated rate in cancer patients. Journal of Immunotherapy: Official Journal of the Society for Biological Therapy 10(6): 440-447
Bukowski, R.M.; Inoshita, G.; Yalavarthi, P.; Murthy, S.; Gibson, V.; Budd, G.T.; Sergi, J.S.; Bauer, L.; Prestifilippo, J. 1992: A phase i trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma. Cancer 69(4): 889-892
Bailey, H.; Wilding, G.; Tutsch, K.D.; Arzoomanian, R.Z.; Alberti, D.; Tombes, M.B.; Grem, J.L.; Spriggs, D.R. 1992: A phase i trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions. Cancer ChemoTherapy and Pharmacology 30(4): 297-302
Lipton, A.; Harvey, H.A.; Demers, L.M.; Hanagan, J.R.; Mulagha, M.T.; Kochak, G.M.; Fitzsimmons, S.; Sanders, S.I.; Santen, R.J. 1990: A phase i trial of CGS 16949A. a new aromatase inhibitor. Cancer 65(6): 1279-1285
Bleiberg, H.; Piccart, M.; Lips, S.; Panzer, J.M.; N'Koua Mbon, J.B. 1992: A phase i trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 3(2): 141-143
Bernard, S.; Gill, P.; Rosen, P.; Gavigan, M.; Steagall, A.; Ellingham, E.; Morgan, T.; Janic, G.; Ozer, H. 1991: A phase i trial of alpha-interferon in combination with pentostatin in hematologic malignancies. Medical and Pediatric Oncology 19(4): 276-282
Saltz, L.; Kelsen, D. 1990: A phase i trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies. Cancer 66(8): 1688-1691
Einzig, A. 1990: A phase i trial of combination chemotherapy employing carboplatin vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors. Cancer Investigation 8(2): 229-230
Posner, M.R.; Ferrari, L.; Belliveau, J.F.; Cummings, F.J.; Wiemann, M.C.; O'Rourke, A.; Weitberg, A.B.; Calabresi, P. 1987: A phase i trial of continuous infusion cisplatin. Cancer 59(1): 15-18
Eder, J.P.; Elias, A.D.; Ayash, L.; Wheeler, C.A.; Shea, T.C.; Schnipper, L.E.; Frei, E.; Antman, K.H. 1991: A phase i trial of continuous-infusion cyclophosphamide in refractory cancer patients. Cancer ChemoTherapy and Pharmacology 29(1): 61-65
Blumenreich, M.S.; Woodcock, T.M.; Richman, S.P.; Jones, M.K.; Gentile, P.S.; Kubota, T.T.; Allegra, J.C. 1985: A phase i trial of dactinomycin intravenous infusion in patients with advanced malignancies. Cancer 56(2): 256-258
Taylor, C.W.; Modiano, M.R.; Woodson, M.E.; Marcus, S.G.; Alberts, D.S.; Hersh, E.M. 1992: A phase i trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancy. Seminars in Oncology 19(2 Suppl 3: 185-190
Anonymous 1991: A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse. Human Gene Therapy 2(3): 273-286
Kamada, M.; Wada, R.; Kumanomido, T.; Imagawa, H.; Sugiura, T.; Fukunaga, Y. 1991: Effect of viral inoculum size on appearance of clinical signs in equine Getah virus infection. Journal of Veterinary Medical Science 53(5): 803-806
Stiff, P.J.; McKenzie, R.S.; Potempa, L.D.; Albain, K.; Koch, D.; Braud, E.; Bansal, V.K.; Weidner, M.K.; Lanzotti, V.J.; Chun, H.G. 1991: A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 9(8): 1487-1494
Ogawa, M.; Kimura, K.; Taguchi, T.; Wakui, A.; Hattori, M.; Shimoyama, T.; Fujita, H. 1987: A phase i trial of idarubicin by oral administration. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1896-1900
Kreuser, E.D.; Hilgenfeld, R.U.; Matthias, M.; Hoksch, B.; Boewer, C.; Oldenkott, B.; Knauf, W.U.; Boese-Landgraf, J.; Schalhorn, A.; Zeitz, M. 1992: A phase i trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Seminars in Oncology 19(2 Suppl 3: 197-203
Schiller, J.H.; Hawkins, M.J.; O'Connell, M.J.; Sielaff, K.; Borden, E.C. 1989: A phase i trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin. Journal of Biological Response Modifiers 8(3): 252-261
D'Acquisto, R.; Markman, M.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J.L. 1988: A phase i trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 6(4): 689-695
Chapman, P.B.; Kolitz, J.E.; Hakes, T.B.; Gabrilove, J.L.; Welte, K.; Merluzzi, V.J.; Engert, A.; Bradley, E.C.; Konrad, M.; Mertelsmann, R. 1988: A phase i trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma. Investigational new Drugs 6(3): 179-188
Feinberg, B.; Kurzrock, R.; Talpaz, M.; Blick, M.; Saks, S.; Gutterman, J.U. 1988: A phase i trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 6(8): 1328-1334
Flamm, E.S.; Young, W.; Collins, W.F.; Piepmeier, J.; Clifton, G.L.; Fischer, B. 1985: A phase i trial of naloxone treatment in acute spinal cord injury. Journal of Neurosurgery 63(3): 390-397
Dhingra, K.; Talpaz, M.; Dhingra, H.M.; Ajani, J.A.; Rothberg, J.M.; Gutterman, J.U. 1991: A phase i trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinum. Investigational new Drugs 9(1): 37-39
Foon, K.A.; Sherwin, S.A.; Abrams, P.G.; Stevenson, H.C.; Holmes, P.; Maluish, A.E.; Oldham, R.K.; Herberman, R.B. 1985: A phase i trial of recombinant gamma interferon in patients with cancer. Cancer Immunology Immunotherapy: Cii 20(3): 193-197
Perez, R.; Lipton, A.; Harvey, H.A.; Simmonds, M.A.; Romano, P.J.; Imboden, S.L.; Giudice, G.; Downing, M.R.; Alton, N.K. 1988: A phase i trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy. Journal of Biological Response Modifiers 7(3): 309-317
Lane, H.C.; Davey, R.T.; Sherwin, S.A.; Masur, H.; Rook, A.H.; Manischewitz, J.F.; Quinnan, G.V.; Smith, P.D.; Easter, M.E.; Fauci, A.S. 1989: A phase i trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Journal of Clinical Immunology 9(4): 351-361
Crown, J.; Jakubowski, A.; Kemeny, N.; Gordon, M.; Gasparetto, C.; Wong, G.; Sheridan, C.; Toner, G.; Meisenberg, B.; Botet, J. 1991: A phase i trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood 78(6): 1420-1427
Zamkoff, K.W.; Hudson, J.; Groves, E.S.; Childs, A.; Konrad, M.; Rudolph, A.R. 1992: A phase i trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy. Journal of Immunotherapy: Official Journal of the Society for Biological Therapy 11(2): 103-110
Demetri, G.D.; Spriggs, D.R.; Sherman, M.L.; Arthur, K.A.; Imamura, K.; Kufe, D.W. 1989: A phase i trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(10): 1545-1553
Croghan, M.K.; Booth, A.; Meyskens, F.L. 1988: A phase i trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma. Journal of Biological Response Modifiers 7(4): 409-415
Redman, B.G.; Flaherty, L.; Chou, T.H.; al-Katib, A.; Kraut, M.; Martino, S.; Chen, B.; Kaplan, J.; Valdivieso, M. 1990: A phase i trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(7): 1269-1276
Schwartz, J.E.; Scuderi, P.; Wiggins, C.; Rudolph, A.; Hersh, E.M. 1989: A phase i trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy. BioTherapy 1(3): 207-214
Zamkoff, K.W.; Newman, N.B.; Rudolph, A.R.; Young, J.; Poiesz, B.J. 1989: A phase i trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy. Journal of Biological Response Modifiers 8(5): 539-552
Brown, T.; Havlin, K.; Weiss, G.; Cagnola, J.; Koeller, J.; Kuhn, J.; Rizzo, J.; Craig, J.; Phillips, J.; Von Hoff, D. 1991: A phase I trial of taxol given by a 6-hour intravenous infusion. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(7): 1261-1267
Weiner, S.A.; Surwit, E.A.; Graham, V.E.; Meyskens, F.L. 1986: A phase i trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Investigational new Drugs 4(3): 241-244
Hamm, J.T. 1990: A phase i trial of toremifene, a new antiestrogen. Cancer Investigation 8(2): 273-274
Grochow, L.B.; Noe, D.A.; Ettinger, D.S.; Donehower, R.C. 1989: A phase i trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics. Cancer ChemoTherapy and Pharmacology 24(5): 314-320
Ardalan, B.; Sridhar, K.S.; Benedetto, P.; Richman, S.; Waldman, S.; Morrell, L.; Feun, L.; Savaraj, N.; Fodor, M.; Livingstone, A. 1991: A phase I, Ii study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies. Cancer 68(6): 1242-1246
Etienne, S.D.; Montay, G.; Le Liboux, A.; Frydman, A.; Garaud, J.J. 1992: A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. Journal of Antimicrobial ChemoTherapy 30 Suppl A: 123-131
Anasetti, C.; Martin, P.J.; Hansen, J.A.; Appelbaum, F.R.; Beatty, P.G.; Doney, K.; Harkonen, S.; Jackson, A.; Reichert, T.; Stewart, P. 1990: A phase I-Ii study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. Transplantation 50(1): 49-54
Sinnige, H.A.; Nanninga, A.G.; Verschueren, R.C.; Sleijfer, D.T.; de Vries, G.E.; Willemse, P.H.; Mulder, N.H. 1992: A phase I-Ii study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma. European Journal of Cancer 28a (4-5): 885-888
Williams, S.F.; Bitran, J.D.; Kaminer, L.; Westbrook, C.; Jacobs, R.; Ashenhurst, J.; Robin, E.; Purl, S.; Beschorner, J.; Schroeder, C. 1987: A phase I-Ii study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(2): 260-265
Eder, J.P.; Elias, A.; Shea, T.C.; Schryber, S.M.; Teicher, B.A.; Hunt, M.; Burke, J.; Siegel, R.; Schnipper, L.E.; Frei, E. 1990: A phase I-Ii study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(7): 1239-1245
Bishop, J.F.; Joshua, D.E.; Lowenthal, R.M.; Kronenberg, H.; Whiteside, M.G.; Cobcroft, R.; Dodds, A.; Wolf, M.; Manoharan, A. 1986: A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Australian and New Zealand Journal of Medicine 16(1): 48-51
Flaherty, L.E.; Redman, B.G.; Chabot, G.G.; Martino, S.; Gualdoni, S.M.; Heilbrun, L.K.; Valdivieso, M.; Bradley, E.C. 1990: A phase I-Ii study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma. Cancer 65(11): 2471-2477
Ellis, E.D.; Williams, S.F.; Moormeier, J.A.; Kaminer, L.S.; Bitran, J.D. 1990: A phase I-Ii study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. Bone Marrow Transplantation 6(6): 439-442
Javadpour, N.; Lalehzarian, M. 1988: A phase I-Ii study of high-dose recombinant human interleukin-2 in disseminated renal-cell carcinoma. Seminars in Surgical Oncology 4(3): 207-209
Mansi, J.L.; Fisher, C.; Wiltshaw, E.; MacMillan, S.; King, M.; Stuart-Harris, R. 1988: A phase I-Ii study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma. European Journal of Cancer and Clinical Oncology 24(9): 1439-1443
Jones, R.B.; Holland, J.F.; Bhardwaj, S.; Norton, L.; Wilfinger, C.; Strashun, A. 1987: A phase I-Ii study of intensive-dose adriamycin for advanced breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(2): 172-177
Davis, M.; Williford, S.; Muss, H.B.; White, D.R.; Cooper, M.R.; Jackson, D.V.; Barrett, R. 1992: A phase I-Ii study of recombinant intrapleural alpha interferon in malignant pleural effusions. American Journal of Clinical Oncology 15(4): 328-330
Krook, J.E.; Jett, J.R.; Little, C. 1989: A phase I-Ii study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer. American Journal of Clinical Oncology 12(2): 114-117
Palmeri, S.; Russo, A.; Gebbia, V.; Borsellino, N.; Gebbia, N.; Rustum, Y.; Rausa, L. 1990: A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma. Journal of ChemoTherapy 2 Suppl. 1: 28-32
Forastiere, A.A.; Natale, R.B.; Takasugi, B.J.; Goren, M.P.; Vogel, W.C.; Kudla-Hatch, V. 1987: A phase I-Ii trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(2): 190-196
Herman, T.S.; Jochelson, M.S.; Teicher, B.A.; Scott, P.J.; Hansen, J.; Clark, J.R.; Pfeffer, M.R.; Gelwan, L.E.; Molnar-Griffin, B.J.; Fraser, S.M. 1989: A phase I-Ii trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. International Journal of Radiation Oncology Biology Physics 17(6): 1273-1279
Posner, M.; Slapak, C.A.; Browne, M.J.; Clark, J.W.; Curt, G.; Weitberg, A.; Calabresi, P.; Cummings, F.J.; Wiemann, M.; Urba, S. 1990: A phase I-Ii trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma. American Journal of Clinical Oncology 13(5): 455-458
Castro, J.R.; Saunders, W.M.; Austin-Seymour, M.M.; Woodruff, K.H.; Gauger, G.; Chen, G.T.; Collier, J.M.; Phillips, T.L.; Zink, S.R. 1985: A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: a Northern California Oncology Group Study. International Journal of Radiation Oncology Biology Physics 11(10): 1795-1800
Grégoire, V.; Beauduin, M.; Humblet, Y.; Hamoir, M.; Longueville, J.; Majois, F.; Remacle, F.M.; Rousseau, F.; Salamon, E.; Wambersie, A. 1991: A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 9(8): 1385-1392
Droz, J.P.; Pico, J.L.; Hayat, M.; Kamioner, D.; Gouyette, A.; Beaujean, F. 1985: A phase I-Ii trial of intensive chemotherapy (CT) with autologous bone-marrow transplantation (ABMT) in metastatic malignant germ cell tumors of the testis (NSGCTT). Progress in Clinical and Biological Research 203: 449-450
Berek, J.S.; Welander, C.; Schink, J.C.; Grossberg, H.; Montz, F.J.; Zigelboim, J. 1991: A phase I-Ii trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancer. Gynecologic Oncology 40(3): 237-243
Kersh, C.R.; Constable, W.C.; Spaulding, C.A.; Hahn, S.S.; Andersen, W.A.; Taylor, P.T. 1990: A phase I-Ii trial of multimodality management of bulky gynecologic malignancy. Combined chemoradiosensitization and radiotherapy. Cancer 66(1): 30-34
Robinson, R.A.; DeVita, V.T.; Levy, H.B.; Baron, S.; Hubbard, S.P.; Levine, A.S. 1976: A phase I-Ii trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. Journal of the National Cancer Institute 57(3): 599-602
Creagan, E.T.; Loprinzi, C.L.; Ahmann, D.L.; Schaid, D.J. 1988: A phase I-Ii trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Cancer 62(12): 2472-2474
Wallack, M.K.; McNally, K.; Michaelides, M.; Bash, J.; Bartolucci, A.; Siegler, H.; Balch, C.; Wanebo, H. 1986: A phase I/Ii SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). American Surgeon 52(3): 148-151
Witte, R.S.; Pruitt, B.; Tormey, D.C.; Moss, S.; Rose, D.P.; Falkson, G.; Carbone, P.P.; Ramirez, G.; Falkson, H.; Pretorius, F.J. 1986: A phase I/Ii investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects. Cancer 57(1): 34-39
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J. 1991: A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG). Progress in Clinical and Biological Research 366: 463-469
Chamberlain, M.C.; Prados, M.D.; Silver, P.; Levin, V.A. 1988: A phase I/Ii study of 24 hour intravenous AZQ in recurrent primary brain tumors. Journal of Neuro-Oncology 6(4): 319-323
Green, D.M.; Burton, G.V.; Cox, E.B.; Hanson, D.; Moore, J.; Oleson, J.R. 1989: A phase I/Ii study of combined cisplatin and hyperthermia treatment for refractory malignancy. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 5(1): 13-21
Hovgaard, D.; Nissen, N.I. 1992: A phase I/Ii study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas. Leukemia and Lymphoma 7(3): 217-224
Parnes, H.L.; Abrams, J.S.; Tchekmedyian, N.S.; Tait, N.; Aisner, J. 1991: A phase I/Ii study of high-dose megestrol acetate in the treatment of metastatic breast cancer. Breast Cancer Research and Treatment 18(3): 171-177
Delgado, G.; Potkul, R.K.; Treat, J.A.; Lewandowski, G.S.; Barter, J.F.; Forst, D.; Rahman, A. 1989: A phase I/Ii study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. American Journal of Obstetrics and Gynecology 160(4): 812
Anger, B.; Porzsolt, F.; Leichtle, R.; Heinze, B.; Bartram, C.; Heimpel, H. 1989: A phase I/Ii study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. Blut 58(6): 275-278
Kaplan, L.D.; Abrams, D.I.; Sherwin, S.A.; Kahn, J.; Volberding, P.A. 1989: A phase I/Ii study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. Biotechnology Therapeutics 1(3): 229-236
Smith, D.B.; Newlands, E.S.; Rustin, G.J.; Begent, R.H.; Crawford, S.M.; Bagshawe, K.D.; Carruthers, L. 1990: A phase I/Ii study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy. Cancer ChemoTherapy and Pharmacology 25(4): 291-294
Lee, D.J.; Pajak, T.F.; Stetz, J.; Order, S.E.; Weissberg, J.B.; Fischer, J.J. 1989: A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). International Journal of Radiation Oncology Biology Physics 16(2): 465-470
Evans, R.G.; Kimler, B.F.; Morantz, R.A.; Vats, T.S.; Gemer, L.S.; Liston, V.; Lowe, N. 1990: A phase I/Ii study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. International Journal of Radiation Oncology Biology Physics 19(2): 415-420
Byers, V.S.; Levin, A.S.; Waites, L.A.; Starrett, B.A.; Mayer, R.A.; Clegg, J.A.; Price, M.R.; Robins, R.A.; Delaney, M.; Baldwin, R.W. 1990: A phase I/Ii study of trichosanthin treatment of HIV disease. Aids 4(12): 1189-1196
Zelkowitz, R.S.; Posner, M.R.; Cummings, F.; Beitz, J.; Weitberg, A.B. 1989: A phase I/Ii trial of 5-fluorouracil and etoposide in metastatic colorectal carcinoma. American Journal of Clinical Oncology 12(6): 491-493
Guinan, E.C.; Sieff, C.A.; Oette, D.H.; Nathan, D.G. 1990: A phase I/Ii trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76(6): 1077-1082
Flad, H.D.; Ernst, M.; Kern, P. 1986: A phase I/Ii trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells. Lymphokine Research 5(Suppl 1): S171-S176
Patanaphan, V.; Salazar, O.M.; Slawson, R.G.; Sewchand, W. 1988: A phase I/Ii trial of whole-abdominal plus pelvic irradiation for Astler-Coller stage beta 2, C colorectal cancer. American Journal of Clinical Oncology 11(1): 60-65
Ernstoff, M.S.; Nair, S.; Bahnson, R.R.; Miketic, L.M.; Banner, B.; Gooding, W.; Day, R.; Whiteside, T.; Hakala, T.; Kirkwood, J.M. 1990: A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(10): 1637-1649
Roila, F.; Basurto, C.; Minotti, V.; Ballatori, E.; Tonato, M. 1986: A phase Ii antiemetic combination (COMD) for cisplatin-induced nausea and vomiting. Cancer ChemoTherapy and Pharmacology 18(1): 88-89
Koyama, H.; Ogawa, M.; Kuraishi, Y.; Tominaga, K.; Yoshida, M.; Taguchi, T. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(7): 1049-1053
Noda, K.; Ikeda, M.; Yakushiji, M.; Nishimura, H.; Terashima, Y.; Sasaki, H.; Hata, T.; Kuramoto, H.; Tanaka, K.; Takahashi, T. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 885-892
Taguchi, T.; Wakui, A.; Nabeya, K.; Kurihara, M.; Isono, K.; Kakegawa, T.; Ota, K. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 483-488
Furuse, K.; Fukuoka, M.; Kurita, Y.; Ariyoshi, Y.; Niitani, H.; Yoneda, S.; Fujii, M.; Hasegawa, K.; Nishiwaki, Y.; Tamura, M. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 879-884
Wang, J.C.; Walle, A.; Novogrodsky, A.; Suthanthiran, M.; Silver, R.T.; Bander, N.H.; Rubin, A.L.; Stenzel, K.H. 1989: A phase Ii clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(12): 1885-1891
Martínez, J.A.; Martín, G.; Sanz, G.F.; Sempere, A.; Jarque, I.; de la Rubia, J.; Sanz, M.A. 1991: A phase Ii clinical trial of carboplatin infusion in high-risk acute nonlymphoblastic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(1): 39-43
Hilker, D.R.; Gross, M.L.; Knocke, H.W.; Shively, J.M. 1978: The interpretation of the mass spectrum of an ornithine-containing lipid from Thiobacillus thiooxidans. Biomedical Mass Spectrometry 5(1): 64-71
Slayton, R.E.; Blessing, J.A.; DiSaia, P.J.; Phillips, G. 1988: A phase Ii clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. a Gynecologic Oncology Group study. American Journal of Clinical Oncology 11(6): 612-613
Tsuchida, M.; Ohara, A.; Tsukimoto, I.; Hanawa, Y.; Akatsuka, J.; Hoshi, Y.; Ueda, Y.; Yamamoto, M.; Akabane, T.; Komiyama, J. 1988: A phase Ii clinical trial of human urinary CSF (P-100) in pediatric patients. Japanese Journal of Clinical Hematology 29(7): 1041-1049
Dembo, M.; Rubinow, S.I. 1977: A kinetic model of cooperativity in aspartate transcarbamylase. Biophysical Journal 18(3): 245-267
Creagan, E.T.; Chang, M.; Long, H.J.; Rubin, J. 1986: A phase Ii clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer. Head and Neck Surgery 8(3): 153-158
Fiedler, W.; Zeller, W.; Peimann, C.J.; Weh, H.J.; Hossfeld, D.K. 1991: A phase Ii combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer. Klinische Wochenschrift 69(6): 261-268
Bonomi, P.; Blessing, J.; Ball, H.; Hanjani, P.; DiSaia, P.J. 1989: A phase Ii evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecologic Oncology 34(3): 357-359
Zidar, B.L.; Green, S.; Pierce, H.I.; Roach, R.W.; Balcerzak, S.P.; Militello, L. 1988: A phase Ii evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group Study. Investigational new Drugs 6(3): 223-226
Hoffman, M.S.; Kavanagh, J.J.; Roberts, W.S.; LaPolla, J.P.; Fiorica, J.V.; Hewitt, S.; Cavanagh, D. 1991: A phase Ii evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix. Gynecologic Oncology 40(2): 144-146
Long, H.J.; Laurie, J.A.; Wieand, H.S.; Edmonson, J.H.; Levitt, R.; Krook, J.E.; Abu-Ghazaleh, S. 1991: A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. Cancer 68(4): 730-732
Hamazoe, R.; Murakami, A.; Hirooka, Y.; Maeta, M.; Kaibara, N. 1991: A phase Ii pilot study of the combined application of hyperthermia and intra-hepato-arterial chemotherapy using cisplatinum and 5-fluorouracil. Journal of Surgical Oncology 48(2): 127-132
Kolitz, J.E.; Kempin, S.J.; Schluger, A.; Wong, G.Y.; Berman, E.; Jhanwar, S.; Arlin, Z.A.; Gee, T.; Clarkson, B.D. 1992: A phase Ii pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. Seminars in Oncology 19(3 Suppl 9: 27-33
Mortimer, J.E.; Crowley, J.; Eyre, H.; Weiden, P.; Eltringham, J.; Stuckey, W.J. 1992: A phase Ii randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. a Southwest Oncology Group study. Cancer 69(5): 1220-1223
Patel, S.R.; Kvols, L.K.; Hahn, R.G.; Windschitl, H.; Levitt, R.; Therneau, T. 1990: A phase Ii randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer 66(4): 655-658
Talpaz, M.; Kurzrock, R.; Kantarjian, H.; Rothberg, J.; Saks, S.; Evans, L.; Gutterman, J.U. 1991: A phase Ii study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia. Cancer 68(10): 2125-2130
Kimura, K. 1986: A phase Ii study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 368-375
Takeda, C. 1986: A phase Ii study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1970-1979
Shepherd, F.A.; Burkes, R.L.; Paul, K.E.; Goss, P.E. 1991: A phase Ii study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. Aids 5(3): 305-309
Rankin, E.M.; Knight, R.K.; Rubens, R.D. 1987: A phase Ii study of 4-deoxydoxorubicin in advanced breast cancer. European Journal of Cancer and Clinical Oncology 23(7): 1079-1080
Fosså, S.D.; Splinter, T.; Roozendaal, K.J.; Veenhof, K.H.; Pavone-Macaluso, M.; Calciati, A.; de Pauw, M.; Sylvester, R. 1989: A phase Ii study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867. European Journal of Cancer and Clinical Oncology 25(2): 389-390
Alberts, A.S.; Schoeman, L.; Burger, W.; Greef, F.; Falkson, G. 1992: A phase Ii study of 5-fluorouracil and leucovorin in advanced carcinoma of the esophagus. American Journal of Clinical Oncology 15(1): 35-36
Walker, S.J.; Allen, S.M.; Steel, A.; Cullen, M.H.; Matthews, H.R. 1991: A phase Ii study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus. Clinical Oncology 3(6): 318-322
Kaern, J.; Tropé, C.; Kjørstad, K.E.; Nordal, R.; Sundfør, K.; Vergote, I.; Vossli, S.; Abeler, V.; Sandvei, R. 1990: A phase Ii study of 5-fluorouracil/cisplatin in recurrent cervical cancer. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(21): 2759-2762
Kaern, J.; Tropé, C.; Abeler, V.; Iversen, T.; Kjørstad, K. 1990: A phase Ii study of 5-fluorouracil/cisplatinum in recurrent cervical cancer. Acta Oncologica 29(1): 25-28
Taguchi, T.; Terasawa, T. 1987: A phase Ii study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(2): 467-471
Cobleigh, M.A.; Hill, J.H.; Gallagher, P.A.; Kukla, L.J.; Lad, T.E.; Shevrin, D.H.; Applebaum, E.L.; McGuire, W.P. 1985: A phase Ii study of Adriamycin in previously untreated squamous cell carcinoma of the head and neck. Cancer 56(11): 2573-2575
Bleehen, N.M.; Roberts, J.T.; Newman, H.F. 1986: A phase Ii study of CCNU with benznidazole for metastatic malignant melanoma. International Journal of Radiation Oncology Biology Physics 12(8): 1401-1403
McGuire, W.P.; Blessing, J.A.; Hatch, K.; DiSaia, P.J. 1986: A phase Ii study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Investigational new Drugs 4(2): 181-186
Negoro, S.; Fukuoka, M.; Niitani, H.; Suzuki, A.; Nakabayashi, T.; Kimura, M.; Motomiya, M.; Kurita, Y.; Hasegawa, K.; Kuriyama, T. 1991: A phase Ii study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(6): 1013-1019
Fukuoka, M.; Niitani, H.; Suzuki, A.; Motomiya, M.; Hasegawa, K.; Nishiwaki, Y.; Kuriyama, T.; Ariyoshi, Y.; Negoro, S.; Masuda, N. 1992: A phase Ii study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(1): 16-20
Romano, C.F.; Lipton, A.; Harvey, H.A.; Simmonds, M.A.; Romano, P.J.; Imboden, S.L. 1985: A phase Ii study of Catrix-S in solid tumors. Journal of Biological Response Modifiers 4(6): 585-589
Aoyama, H.; Kubo, K.; Uchino, J.; Hayasaka, H.; Asaishi, K.; Izuo, M.; Ogawa, M.; Majima, H.; Yasutomi, M.; Wada, T. 1992: A phase Ii study of DWA2114R, a new platinum complex for breast cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(7): 1033-1039
Ohyama, M.; Matsumura, M.; Katsuta, K.; Nobori, T.; Furuta, S.; Matsunaga, S.; Uchizono, A.; Hanada, T.; Moriyama, I.; Kamachi, S. 1988: A phase Ii study of Futraful suppository in head and neck cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(7): 2093-2100
Blackledge, G.; Verweij, J.; Fuchs, R.; Keizer, H.J.; Somers, R.; Rankin, E.; Kerbrat, P.; van Oosterom, A.; Sylvester, R.; Thomas, D. 1989: A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study. European Journal of Cancer and Clinical Oncology 25(12): 1891-1893
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Kimura, K.; Niitani, H. 1985: A phase Ii study of NK171 (etoposide). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(10): 2011-2017
Depierre, A.; Lemarie, E.; Dabouis, G.; Garnier, G.; Jacoulet, P.; Dalphin, J.C. 1991: A phase Ii study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer. American Journal of Clinical Oncology 14(2): 115-119
Tsushima, K.; Sakata, Y.; Munakata, A.; Sato, T.; Chiba, Y.; Nara, H.; Kawazu, S.; Matsukawa, M.; Ohmi, T.; Aizawa, T. 1991: A phase Ii study of SM-5887 for advanced gastric cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(7): 1151-1154
Shimizu, E.; Kimura, K.; Sone, S.; Inoue, I.; Nakamura, Y.; Noda, Y.; Hojo, F.; Yagi, M.; Nakanishi, S.; Yamasaki, K. 1986: A phase Ii study of UFT in non-small cell lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(10): 2970-2973
Eisenhauer, E.A.; Evans, W.K.; Murray, N.; Kocha, W.; Wierzbicki, R.; Wilson, K. 1988: A phase Ii study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCi Canada Clinical Trials Group Study. Investigational new Drugs 6(4): 327-329
Meyskens, F.L.; Kingsley, E.M.; Glattke, T.; Loescher, L.; Booth, A. 1986: A phase Ii study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Investigational new Drugs 4(3): 257-262
Osby, E.; Reizenstein, P.; Mathé, G.; Peetermans, M.; Blanc, C.M.; Cauchie, C.; Fiere, D.; Jaubert, M. 1985: A phase Ii study of alternating combination chemotherapy in 55 myeloma patients. a comparison with non-alternating combination chemotherapy and treatment with a single cytostatic. Anticancer Research 5(4): 339-342
Miller, T.P.; Cowan, J.D.; Neilan, B.A.; Jones, S.E. 1986: A phase Ii study of bisantrene in malignant lymphomas. a Southwest Oncology Group Study. Cancer ChemoTherapy and Pharmacology 16(1): 67-69
Smit, E.F.; Berendsen, H.H.; de Vries, E.G.; Mulder, N.H.; Postmus, P.E. 1989: A phase Ii study of carboplatin and vincristine in previously treated patients with small-cell lung cancer. Cancer ChemoTherapy and Pharmacology 25(3): 202-204
Beer, M.; Cavalli, F.; Kaye, S.B.; Lev, L.M.; Clavel, M.; Smyth, J.; van Glabbeke, M.; Renard, J.; Pinedo, H.M. 1987: A phase Ii study of carboplatin in advanced or metastatic stomach cancer. European Journal of Cancer and Clinical Oncology 23(10): 1565-1567
Arseneau, J.; Blessing, J.A.; Stehman, F.B.; McGehee, R. 1986: A phase Ii study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Investigational new Drugs 4(2): 187-191
Kawakami, A.; Ishida, O.; Suzuki, T. 1988: Effect of intra-arterially injected cisplatinum and lipiodol on the rat liver. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2787-2792
Kroese, F.G.; Wubbena, A.S.; Seijen, H.G.; Nieuwenhuis, P. 1987: Germinal centers develop oligoclonally. European Journal of Immunology 17(7): 1069-1072
Komatsu, H.; Furuse, K.; Nishikawa, H.; Minoda, S.; Saotome, K.; Nemoto, E.; Tani, Y.; Saito, T.; Ishiwata, K.; Tsutsumi, M. 1988: A phase Ii study of carboplatin in small cell lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(8): 2313-2318
Kato, N.; Halprin, K.M.; Taylor, J.R.; Ohkawara, A. 1988: Cyclosporin a induced augmentation of the beta-adrenergic adenylate cyclase response of pig epidermis. Archives of Dermatological Research 280(2): 89-92
Whitehead, R.P.; Fleming, T.R.; Macdonald, J.S.; Ahmann, F.R.; Garewal, H.S.; Kuebler, J.P. 1991: A phase Ii study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. a Southwest Oncology Group study. Investigational new Drugs 9(4): 345-347
Tellez-Bernal, E.; Recondo, G.; Guillot, T.; Benhamed, M.; Domenge, C.; Izzo, J.; Cvitkovic, E.; Armand, J.P. 1990: A phase Ii study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer. Cancer 66(4): 640-644
Shibata, J.; Kimura, S.; Nakashima, M.; Nakazono, K.; Miyase, S.; Sakai, M.; Fujiyama, S.; Sato, T. 1989: Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 1): 357-364
Jones, A.S.; Phillips, D.E.; Field, J.K. 1992: A phase Ii study of cisplatinum versus cisplatinum + nifedipine in end-stage carcinoma of the head and neck. Clinical Otolaryngology and Allied Sciences 17(6): 501-504
Moertel, C.G.; Rubin, J.; O'Connell, M.J.; Schutt, A.J.; Wieand, H.S. 1986: A phase Ii study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 4(7): 1053-1057
Tropé, C.; Mattsson, W.; Astedt, B. 1977: A phase Ii study of combined adriamycin, L-PAM, and methotrexate with citrovorum factor rescue in advanced ovarian carcinomas. Tumori 63(5): 469-477
Smalley, R.V.; Goldstein, D.; Bulkowski, D.; Hannon, C.; Buchler, D.; Knudsen, C.; Tuttle, R.L. 1992: A phase Ii study of crisnatol mesylate in patients with ovarian carcinoma. Investigational new Drugs 10(2): 107-112
Rosell, R.; Carles, J.; Ariza, A.; Moreno, I.; Ribelles, N.; Solano, V.; Pellicer, I.; Barnadas, A.; Abad, A. 1991: A phase Ii study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer. Cancer 67(10): 2448-2453
Ettinger, L.J.; Krailo, M.; Ruccione, K.S.; Krivit, W.; Hammond, G.D. 1988: A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group. American Journal of Pediatric Hematology/Oncology 10(1): 18-22
Ettinger, L.J.; Ru, N.; Krailo, M.; Ruccione, K.S.; Krivit, W.; Hammond, G.D. 1990: A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group. Journal of Neuro-Oncology 9(1): 69-76
Ettinger, L.J.; Ru, N.; Krailo, M.D.; Ruccione, K.S.; Krivit, W.A.; Hammond, G.D. 1990: A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group. American Journal of Pediatric Hematology/Oncology 12(3): 301-305
Arseneau, J.C.; Schoenfeld, D.A.; Borden, E.C. 1986: A phase Ii study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma. Investigational new Drugs 4(1): 53-56
Alberto, P.; Jungi, W.F.; Siegenthaler, P.; Mermillod, B.; Obrecht, J.P.; Decoster, G.; Cavalli, F. 1988: A phase Ii study of doxifluridine in patients with advanced breast cancer. European Journal of Cancer and Clinical Oncology 24(3): 565-566
Sampi, K.; Masaoka, T.; Shibata, H.; Shirakawa, S.; Kobayashi, T.; Shirai, T.; Umeda, M.; Kozuru, M.; Sugiyama, H.; Oguro, M. 1986: A phase Ii study of epirubicin in acute leukemia: a cooperative group study. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(8): 2594-2599
Furuse, K.; Fukuoka, M.; Yamamoto, M.; Kawahara, M.; Tsuruta, M.; Kodama, N.; Arai, R.; Hayashi, S.; Kiyota, M.; Kubota, K. 1986: A phase Ii study of epirubicin in advanced lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2835-2840
Masaoka, T.; Shibata, H.; Sampi, K.; Hirota, Y.; Yoshida, Y.; Chiba, Y.; Shirakawa, S.; Kobayashi, T.; Toki, H.; Tamura, K. 1986: A phase Ii study of epirubicin in malignant lymphoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(8): 2606-2611
Furuse, K. 1985: A phase Ii study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(12): 2352-2357
Kado, M.; Oshima, S.; Matsui, Y.; Shimokata, K.; Hara, K.; Kanda, T.; Shima, K.; Takenaka, S. 1986: A phase Ii study of etoposide (VP-16) injection in primary lung cancer by cooperative study group. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(1): 116-121
Tropé, C.; Kaern, J.; Vergote, I.; Vossli, S. 1990: A phase Ii study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas. Cancer ChemoTherapy and Pharmacology 26 Suppl: S45-S47
Stahl, M.; Wilke, H.; Schmoll, H.J.; Schöber, C.; Diedrich, H.; Casper, J.; Freund, M.; Poliwoda, H. 1992: A phase Ii study of high dose tamoxifen in progressive, metastatic renal cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 3(2): 167-168
Philip, T.; Ghalie, R.; Pinkerton, R.; Zucker, J.M.; Bernard, J.L.; Leverger, G.; Hartmann, O. 1987: A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 5(6): 941-950
Dutcher, J.P.; Gaynor, E.R.; Boldt, D.H.; Doroshow, J.H.; Bar, M.H.; Sznol, M.; Mier, J.; Sparano, J.; Fisher, R.I.; Weiss, G. 1991: A phase Ii study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(4): 641-648
Antman, K.; Ayash, L.; Elias, A.; Wheeler, C.; Hunt, M.; Eder, J.P.; Teicher, B.A.; Critchlow, J.; Bibbo, J.; Schnipper, L.E. 1992: A phase Ii study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(1): 102-110
Martoni, A.; Guaraldi, M.; Casadio, M.; Busutti, L.; Pannuti, F. 1992: A phase Ii study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC). Annals of Oncology: Official Journal of the European Society for Medical Oncology 3(10): 864-866
Citrin, D.L.; Kies, M.S.; Wallemark, C.B.; Khandekar, J.; Kaplan, E.; Camacho, F.; Lind, R. 1985: A phase Ii study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer 56(3): 457-460
Wagstaff, J.; Loynds, P.; Crowther, D. 1986: A phase Ii study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma. Cancer ChemoTherapy and Pharmacology 18(1): 54-58
Chisesi, T.; Capnist, G.; de Dominicis, E.; Dini, E. 1988: A phase Ii study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma. European Journal of Cancer and Clinical Oncology 24(4): 681-684
MacCormick, R.; Hirsch, G.; Gupta, S.; Shannon, P.; Rotstein, L. 1991: A phase Ii study of idarubicin in the treatment of measurable gastric cancer. Cancer 67(12): 2988-2989
Lind, M.J.; Gomm, S.; Simmonds, A.P.; Ashcroft, L.; Kamthan, A.; Gurney, H.; Thatcher, N. 1991: A phase Ii study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer. Cancer ChemoTherapy and Pharmacology 28(2): 142-144
Coleman, R.E.; Clarke, J.M.; Slevin, M.L.; Sweetenham, J.; Williams, C.J.; Blake, P.; Calman, F.; Wiltshaw, E.; Harper, P.G. 1990: A phase Ii study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix. Cancer ChemoTherapy and Pharmacology 27(1): 52-54
Coleman, R.E.; Harper, P.G.; Gallagher, C.; Osborne, R.; Rankin, E.M.; Silverstone, A.C.; Slevin, M.L.; Souhami, R.L.; Tobias, J.S.; Trask, C.W. 1986: A phase Ii study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer ChemoTherapy and Pharmacology 18(3): 280-283
Pinkerton, C.R.; Rogers, H.; James, C.; Bowman, A.; Barbor, P.R.; Eden, O.B.; Pritchard, J. 1985: A phase Ii study of ifosfamide in children with recurrent solid tumours. Cancer ChemoTherapy and Pharmacology 15(3): 258-262
Pinkerton, C.R.; Pritchard, J. 1989: A phase II study of ifosfamide in paediatric solid tumours. Cancer ChemoTherapy and Pharmacology 24(Suppl 1): S13-S15
Magrath, I.; Sandlund, J.; Raynor, A.; Rosenberg, S.; Arasi, V.; Miser, J. 1986: A phase Ii study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer ChemoTherapy and Pharmacology 18(Suppl 2): S25-S28
Tournade, M.F. 1989: A phase Ii study of ifosfamide in the treatment of relapses in Wilms' tumor. Cancer ChemoTherapy and Pharmacology 24(Suppl 1): S31-S33
Shepherd, F.A.; Goss, P.E.; Latreille, J.; Stewart, D.; Logan, D.; Evans, W.K.; Maroun, J.; Warner, E. 1990: A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report. Seminars in Oncology 17(2 Suppl. 4): 19-23
Cantwell, B.M.; Carmichael, J.; Ghani, S.; Harris, A.L. 1988: A phase Ii study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma. Cancer ChemoTherapy and Pharmacology 21(1): 49-52
Langenbuch, T.; Mross, K.; Jonat, W.; Hossfeld, D.K. 1990: A phase Ii study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer. Cancer ChemoTherapy and Pharmacology 26 Suppl: S93-S96
Dutcher, J.P.; Creekmore, S.; Weiss, G.R.; Margolin, K.; Markowitz, A.B.; Roper, M.; Parkinson, D.; Ciobanu, N.; Fisher, R.I.; Boldt, D.H. 1989: A phase Ii study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 7(4): 477-485
Rubin, J.; Schutt, A.J.; Pitot, H.C. 1992: A phase Ii study of intravenous 6-thioguanine (NSC-752) in advanced colorectal carcinoma. American Journal of Clinical Oncology 15(3): 236-238
Konno, K.; Nagahama, F.; Nakai, Y.; Nakabayashi, T.; Hiraga, Y.; Takebe, K.; Tamura, M.; Oizumi, K.; Sato, M.; Ito, T. 1986: A phase Ii study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 1): 931-937
Chang, P.; Levine, M.A.; Wiernik, P.H.; Walker, M.D. 1976: A phase Ii study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas. Cancer 37(2): 615-619
Whitehead, R.P.; Earhart, R.H.; Fleming, T.; Goodman, P.; Macdonald, J.S.; Pollock, T.; Ungerleider, J.S. 1990: A phase Ii study of menogaril (NSC-269148) in colorectal carcinoma. a Southwest Oncology Group study. Investigational new Drugs 8(3): 295-297
Skillings, J.; Cripps, C.; Eisenhauer, E.; Pater, J.; Verma, S.; Walde, D. 1991: A phase Ii study of menogaril in low-grade non-Hodgkin's lymphoma. An NCi Canada Clinical Trials Group study. Investigational new Drugs 9(1): 79-82
Tranum, B.L.; Haut, A.; Rivkin, S.; Weber, E.; Quagliana, J.M.; Shaw, M.; Tucker, W.G.; Smith, F.E.; Samson, M.; Gottlieb, J. 1975: A phase Ii study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study. Cancer 35(4): 1148-1153
Barrett, J.T.; Orofiamma, B.; Khandekar, J.D.; Carbone, P.P.; Comis, R.L.; Davis, T.E. 1989: A phase Ii study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer 64(12): 2445-2447
Masaoka, T.; Shibata, H.; Oguma, S.; Nagai, K.; Kitani, T.; Horiuchi, A.; Yasunaga, K.; Yonezawa, T.; Kawagoe, H. 1985: A phase Ii study of mitoxantrone in acute leukemia. Investigational new Drugs 3(2): 197-201
Masaoka, T.; Oguma, S.; Shibata, H.; Nagai, K.; Horiuchi, A.; Kitani, T.; Yonezawa, T.; Kawagoe, H.; Yasunaga, K. 1986: A phase Ii study of mitoxantrone in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2793-2799
Pronzato, P.; Ardizzoni, A.; Conte, P.F.; Gulisano, M.; Lionetto, R.; Repetto, L.; Scornavacche, V.; Sertoli, M.R.; Rosso, R. 1986: A phase Ii study of mitoxantrone in advanced breast cancer. Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(3): 150-153
Levi, J.A.; Gill, P.G.; Presgrave, P. 1990: A phase Ii study of mitoxantrone in advanced gastric cancer. Investigational new Drugs 8(3): 305-306
Wheeler, H.; Woods, R.L.; Page, J.; Levi, J. 1990: A phase Ii study of mitoxantrone in advanced squamous cell cancer of the head and neck. Investigational new Drugs 8(1): 109-111
Ibuka, T.; Sasaki, T.; Imai, K.; Sakai, Y. 1986: A phase Ii study of mitoxantrone in malignant lymphoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(8): 2612-2617
Kimura, I.; Ohnoshi, T.; Ogawa, M.; Sampi, K.; Masaoka, T.; Yamada, K.; Ohta, K.; Kitani, T.; Kawagoe, H.; Shirakawa, S. 1986: A phase Ii study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2800-2806
Coleman, R.; Clarke, J.; Gore, M.; Wiltshaw, E.; Slevin, M.; Harper, P. 1989: A phase Ii study of mitozantrone in advanced carcinoma of the ovary. Cancer ChemoTherapy and Pharmacology 24(3): 200-202
Smith, D.B.; Rustin, G.J.; Howells, N.; Lambert, H.E.; McQuade, B. 1991: A phase Ii study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer. the North Thames Ovary Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 607-608
Matsui, Y.; Ohshima, S.; Kado, M.; Nakayama, M.; Shimokata, K.; Sakai, S.; Ito, F.; Chikata, E.; Hara, K.; Kanda, T. 1985: A phase Ii study of oral VP-16 in primary lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1801-1807
Stuart, N.S.; Cullen, M.H.; Priestman, T.J.; Blackledge, G.R.; Tyrrell, C.J. 1988: A phase Ii study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. Cancer ChemoTherapy and Pharmacology 21(4): 351-354
Williams, C.J. 1990: A phase Ii study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma. Cancer ChemoTherapy and Pharmacology 25(4): 304-305
Smith, D.B.; Howell, A. 1987: A phase Ii study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer. European Journal of Cancer and Clinical Oncology 23(4): 391-394
Bennett, J.M.; Frank, J.; Sears, M.; Lagakos, S.W.; Horton, J.; Colsky, J.; Hall, T.C. 1978: A phase II study of phenesterin (NSC-104469). Medical and Pediatric Oncology 4(3): 241-246
Kaukel, E.; Koschel, G.; Gatzemeyer, U.; Salewski, E. 1990: A phase Ii study of pirarubicin in malignant pleural mesothelioma. Cancer 66(4): 651-654
Vokes, E.E.; Dimery, I.W.; Jacobs, C.D.; Karp, D.; Molina, A.; Collier, M.A.; Eble, M.L.; Clendeninn, N.J. 1991: A phase Ii study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer. Cancer 67(9): 2253-2257
Uen, W.C.; Huang, A.T.; Mennel, R.; Jones, S.E.; Spaulding, M.B.; Killion, K.; Havlin, K.; Keegan, P.; Clendeninn, N.J. 1992: A phase Ii study of piritrexim in patients with advanced squamous head and neck cancer. Cancer 69(4): 1008-1011
Paul, R.R.; Sharma, P.L.; Wahi, P.L. 1976: A phase Ii study of prazosin hydrochloride in hypertensive subjects. International Journal of Clinical Pharmacology and Biopharmacy 14(4): 271-274
Duggan, D.B.; Santarelli, M.T.; Zamkoff, K.; Lichtman, S.; Ellerton, J.; Cooper, R.; Poiesz, B.; Anderson, J.R.; Bloomfield, C.D.; Peterson, B.A. 1992: A phase Ii study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. a study of the Cancer and Leukemia Group B. Journal of Immunotherapy: Official Journal of the Society for Biological Therapy 12(2): 115-122
Harding, M.J.; Kaye, S.B.; Soukop, M.; Ferguson, J.C. 1988: A phase Ii study of sequential methotrexate and 5-fluorouracil in colorectal carcinoma. Medical Oncology and Tumor PharmacoTherapy 5(4): 239-241
Panasci, L.; Ford, J.; Margolese, R. 1985: A phase Ii study of sequential methotrexate and fluorouracil in advanced colorectal cancer. Cancer ChemoTherapy and Pharmacology 15(2): 164-166
Fiedler, W.; Jasmin, C.; De Mulder, P.H.; Pyrhönen, S.; Palmer, P.A.; Franks, C.R.; Oskam, R.; Hossfeld, D.K. 1992: A phase Ii study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma. European Journal of Cancer 28(2-3): 443-446
Eisenhauer, E.; Quirt, I.; Connors, J.M.; Maroun, J.; Skillings, J. 1985: A phase Ii study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCi Canada Clinical Trials Group Study. Investigational new Drugs 3(3): 307-310
Sessa, C.; ten Bokkel Huinik, W.; Clavel, M.; Lev, L.M.; Joss, R.A.; Renard, J.; Cavalli, F. 1989: A phase Ii study of spirogermanium in patients with advanced malignant lymphoma. Investigational new Drugs 7(2-3): 219-222
Eisenhauer, E.; Kerr, I.; Bodurtha, A.; Iscoe, N.; McCulloch, P.; Pritchard, K.; Quirt, I. 1985: A phase Ii study of spirogermanium in patients with metastatic malignant melanoma. An NCi Canada Clinical Trials Group Study. Investigational new Drugs 3(3): 303-305
O'Brien, M.E.; Hardy, J.; Tan, S.; Walling, J.; Peters, B.; Hatty, S.; Wiltshaw, E. 1992: A phase Ii study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer. Cancer ChemoTherapy and Pharmacology 30(3): 245-248
Slevin, M.L.; Harvey, V.J.; Osborne, R.J.; Shepherd, J.H.; Williams, C.J.; Mead, G.M. 1986: A phase Ii study of tamoxifen in ovarian cancer. European Journal of Cancer and Clinical Oncology 22(3): 309-312
Einzig, A.I.; Hochster, H.; Wiernik, P.H.; Trump, D.L.; Dutcher, J.P.; Garowski, E.; Sasloff, J.; Smith, T.J. 1991: A phase II study of taxol in patients with malignant melanoma. Investigational new Drugs 9(1): 59-64
Cascinelli, N.; Belli, F.; Marchini, S.; Marolda, R.; Prada, A.; Sciorelli, G.; Villani, F.; Gambacorti-Passerini, C.; Galazka, A.; Parmiani, G. 1989: A phase Ii study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients. Tumori 75(3): 233-244
Le Chevalier, T.; Thomas, F.; Subirana, R.; Baldeyrou, P.; Ruffie, P.; Arriagada, R.; Chazard, M.; Tursz, T. 1991: A phase Ii study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma. Cancer 67(12): 2980-2983
Elliott, T.E.; Moertel, C.G.; Wieand, H.S.; Hahn, R.G.; Gerstner, J.B.; Tschetter, L.K.; Mailliard, J.A. 1990: A phase Ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer. Cancer 65(7): 1491-1494
Cantwell, B.M.; Franks, C.R.; Harris, A.L. 1986: A phase Ii study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma. Cancer ChemoTherapy and Pharmacology 18(3): 286-288
Turner, J.H.; Claringbold, P.G. 1991: A phase Ii study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate. European Journal of Cancer 27(9): 1084-1086
McCreary, R.H.; Moertel, C.G.; Schutt, A.J.; O'Connell, M.J.; Hahn, R.G.; Reitemeier, R.J.; Rubin, J.; Frytak, S. 1977: A phase Ii study of triazinate (NSC 139105) in advanced colorectal carcinoma. Cancer 40(1): 9-13
Mårtensson, G.; Sörenson, S. 1989: A phase II study of vincristine in malignant mesothelioma--a negative report. Cancer ChemoTherapy and Pharmacology 24(2): 133-134
Shimizu, E.; Nakamura, Y.; Yamasaki, K.; Kimura, K.; Inoue, I.; Nakahira, S.; Kawahito, K.; Tani, K.; Sone, S.; Yamashita, T. 1987: A phase Ii study of vindesine for pretreated non-small cell lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2532-2536
Lizuka, T.; Kakegawa, T.; Ide, H.; Ando, N.; Watanabe, H.; Mori, S.; Sasaki, K.; Takagi, I.; Nashimoto, A.; Ishida, K. 1989: A phase Ii study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group. Japanese Journal of Clinical Oncology 19(4): 380-383
Hupperets, P.S.; ten Velde, G.P.; Bron, H.; Schouten, L.; Blijham, G.H. 1991: A phase Ii study of vindesine plus etoposide in metastatic non-small cell lung cancer. European Journal of Cancer 27(5): 674-675
Ardalan, B.; Chua, L.; Tian, E.M.; Reddy, R.; Sridhar, K.; Benedetto, P.; Richman, S.; Legaspi, A.; Waldman, S.; Morrell, L. 1991: A phase Ii study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(4): 625-630
Lelli, G.; Guaraldi, M.; Canova, N.; Casadio, M.; Pannuti, F. 1990: A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC). Journal of ChemoTherapy 2(6): 401-404
Crowson, M.C.; Dorrell, A.; Rolfe, E.B.; Fielding, J.W. 1986: A phase Ii study to evaluate tamoxifen in pancreatic adenocarcinoma. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 12(4): 335-336
Tummarello, D.; Guidi, F.; Di Furia, L.; Gramazio, A.; Menichetti, E.; Cellerino, R. 1989: A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC). Journal of ChemoTherapy 1(1): 64-67
Schornagel, J.H.; Verweij, J.; de Mulder, P.H.; Cognetti, F.; Vermorken, J.B.; Cappelaere, P.; Armand, J.P.; Wildiers, J.; Clavel, M.; Kirkpatrick, A. 1992: A phase Ii trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. the EORTC Head and Neck Cancer Cooperative Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 3(3): 223-226
Kavanagh, J.J.; Copeland, L.J.; Gershenson, D.M.; Saul, P.B.; Edwards, C.L. 1986: A phase Ii trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer. Gynecologic Oncology 24(1): 23-26
Arbuck, S.G.; Douglass, H.O.; Trave, F.; Milliron, S.; Baroni, M.; Nava, H.; Emrich, L.J.; Rustum, Y.M. 1987: A phase Ii trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(8): 1150-1156
Arbuck, S.G.; Douglass, H.O.; Trave, F.; Rustum, Y.M. 1987: A phase Ii trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase i trial of intraperitoneal 5-fluorouracil and leucovorin. Nci Monographs: a Publication of the National Cancer Institute 5: 203-205
Pazdur, R.; Ajani, J.A.; Winn, R.; Bearden, J.; Belt, R.J.; Pilat, S.; Hallinan, R.; Levin, B. 1992: A phase Ii trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma. Cancer 69(4): 878-882
Arbuck, S.G.; Silk, Y.; Douglass, H.O.; Nava, H.; Rustum, Y.M.; Milliron, S. 1990: A phase Ii trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. Cancer 65(11): 2442-2445
Scheithauer, W.; Pfeffel, F.; Kornek, G.; Marczell, A.; Wiltschke, C.; Funovics, J. 1992: A phase Ii trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 70(7): 1864-1866
Casper, E.S.; Baselga, J.; Smart, T.B.; Magill, G.B.; Markman, M.; Ranhosky, A. 1991: A phase Ii trial of PALA + dipyridamole in patients with advanced soft-tissue sarcoma. Cancer ChemoTherapy and Pharmacology 28(1): 51-54
Feldman, L.D.; Feun, L.G.; Benjamin, R.S.; Yap, B.S.; Plager, C.; Papadopoulos, N.; Savaraj, N.; Burgess, M.A.; Bodey, G.P. 1985: A phase Ii trial of PCNU in patients with malignant melanoma and central nervous system metastases. American Journal of Clinical Oncology 8(3): 215-217
Muss, H.B.; Spell, N.; Scudiery, D.; Capizzi, R.L.; Cooper, M.R.; Cruz, J.; Jackson, D.V.; Richards, F.; Spurr, C.L.; White, D.R. 1990: A phase Ii trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma. Investigational new Drugs 8(1): 125-130
Rossi, G.; Mariano, M.R.; Arcangeli, G.; Bonfanti, V.; Capucci, M.A.; Ferremi, P.; Marpicati, P.; Meriggi, F.; Zaniboni, A.; Izzi, T. 1991: A phase Ii trial of ProMACE-CytaBOM in previously untreated non-Hodgkin's lymphoma of intermediate- or high-grade histology. Hematological Oncology 9(3): 147-155
Senra Varela, A.; Millan Nuñez-Cortes, J.; Gallurt Moreira, P. 1988: A phase Ii trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck. Oncology 45(6): 458-460
Eckenrode, J.L.; Wheeler, R.H.; Forastiere, A.A. 1985: A phase Ii trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck. Investigational new Drugs 3(4): 389-392
Dottino, P.R.; Plaxe, S.C.; Cohen, C.J. 1991: A phase Ii trial of adjuvant cisplatin and doxorubicin in stage i epithelial ovarian cancer. Gynecologic Oncology 43(3): 203-205
Kelsen, D.; Martin, D.S.; Colofiore, J.; Sawyer, R.; Coit, D. 1992: A phase Ii trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. Cancer 70(7): 1988-1992
Kavanagh, J.J.; Gershenson, D.M.; Saul, P.B.; Copeland, L.J. 1986: A phase Ii trial of bisantrene (CL216,942) in refractory epithelial ovarian cancer. Gynecologic Oncology 23(1): 40-43
Dmitrovsky, E.; Seifter, E.J.; Gazdar, A.F.; Tsai, C.M.; Edison, M.; Brantley, P.; Veach, S.R.; Batist, G.; Ihde, D.C.; Mulshine, J.L. 1990: A phase Ii trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity. American Journal of Clinical Oncology 13(4): 285-289
Lovett, D.; Kelsen, D.; Eisenberger, M.; Houston, C. 1991: A phase Ii trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer 67(2): 354-356
Weiss, G.R.; Green, S.; Hannigan, E.V.; Boutselis, J.G.; Surwit, E.A.; Wallace, D.L.; Alberts, D.S. 1990: A phase Ii trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecologic Oncology 39(3): 332-336
Pallares, C.; Izquierdo, M.A.; Paredes, A.; Fernandez Sagarra, A.; De Andrés, L.; López López, J.J. 1991: A phase Ii trial of carboplatin in untreated patients with extensive stage small cell lung cancer. Cancer 68(1): 40-43
Gentile, P.S.; Woodcock, T.M.; Blumenreich, M.S.; Epremian, B.E.; Seeger, J.; Sheth, S.P.; Hamm, J.T.; Sherrill, E.J.; Allegra, J.C. 1987: A phase Ii trial of chlorambucil in non-small cell lung cancer. American Journal of Clinical Oncology 10(6): 515-516
Weiss, G.R.; Green, S.; Hannigan, E.V.; Boutselis, J.G.; Surwit, E.A.; Wallace, D.L.; Alberts, D.S. 1990: A phase Ii trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. Gynecologic Oncology 37(3): 354-358
Takasugi, B.J.; Perry, D.J.; Wheeler, R.H.; Forastiere, A.A. 1986: A phase Ii trial of cisplatin and methylglyoxal bis-guanylhydrazone (MGBG) in recurrent squamous cell carcinoma of the head and neck. American Journal of Clinical Oncology 9(4): 299-301
Murphy, P.B.; Hainsworth, J.D.; Greco, F.A.; Hande, K.R.; DeVore, R.F.; Johnson, D.H. 1992: A phase Ii trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer. Cancer 69(2): 370-375
Bukowski, R.M.; Johnson, K.G.; Peterson, R.F.; Stephens, R.L.; Rivkin, S.E.; Neilan, B.; Costanzi, J.H. 1987: A phase Ii trial of combination chemotherapy in patients with metastatic carcinoid tumors. a Southwest Oncology Group Study. Cancer 60(12): 2891-2895
Posner, M.; Martin, A.; Slapak, C.A.; Clark, J.W.; Cummings, F.J.; Robert, N.J.; Sikov, W.; Akerley, W. 1992: A phase Ii trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma. American Journal of Clinical Oncology 15(3): 239-241
Adamson, P.C.; Zimm, S.; Ragab, A.H.; Balis, F.; Steinberg, S.M.; Kamen, B.A.; Vietti, T.J.; Gillespie, A.; Poplack, D.G. 1992: A phase Ii trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer ChemoTherapy and Pharmacology 30(2): 155-157
Adamson, P.C.; Zimm, S.; Ragab, A.H.; Steinberg, S.M.; Balis, F.; Kamen, B.A.; Vietti, T.J.; Gillespie, A.; Poplack, D.G. 1990: A phase Ii trial of continuous-infusion 6-mercaptopurine for childhood solid tumors. Cancer ChemoTherapy and Pharmacology 26(5): 343-344
Kwiatkowski, D.J.; Propert, K.J.; Carey, R.W.; Choi, N.; Green, M. 1987: A phase Ii trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(12): 1874-1879
Rischin, D.; Bishop, J.F.; Olver, I.N.; Laidlaw, C.R.; Zimet, A.; Jeal, P.; Dipell, J.F. 1992: A phase Ii trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer. American Journal of Clinical Oncology 15(5): 392-394
Muñiz, F.; Vélez-García, E.; Neidhart, J.A.; Bender, J.F.; Becker, M.; Grillo-Lopez, A.J. 1987: A phase Ii trial of diaziquone in patients with head and neck cancer. Cancer ChemoTherapy and Pharmacology 19(3): 265-268
Jacobs, A.J.; Blessing, J.A.; Munoz, A. 1992: A phase Ii trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology 44(3): 268-270
Moriyama, Y.; Shibata, A.; Maekawa, I.; Yoshida, Y.; Miura, A.; Wakui, A.; Kariyone, S.; Maekawa, T.; Miura, Y.; Abe, T. 1985: A phase Ii trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia. Japanese Journal of Clinical Hematology 26(11): 1774-1784
Woolley, P.V.; MacDonald, J.S.; Smythe, T.; Haller, D.G.; Hoth, D.F.; Rosenoff, S.; Schein, P.S. 1979: A phase Ii trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinoma. Cancer 44(4): 1211-1214
Steffens, T.A.; Bajorin, D.F.; Chapman, P.B.; Lovett, D.R.; Cody-Johnson, B.V.; Templeton, M.A.; Heelan, R.T.; Wong, G.Y.; Portlock, C.S.; Oettgen, H.F. 1991: A phase Ii trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma. Cancer 68(6): 1230-1237
White, D.R.; Powell, B.L.; Craig, J.B.; Stuart, R.K.; Schnell, F.M.; Goldklang, G.A.; Atkins, J.N.; Jackson, D.V.; Richards, F.; Muss, H.B. 1990: A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study. Cancer 65(8): 1700-1703
Vugrin, D.; Hood, L.; Laszlo, J. 1986: A phase Ii trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma. Journal of Biological Response Modifiers 5(4): 309-312
Carmichael, J.; Cantwell, B.M.; Harris, A.L. 1989: A phase Ii trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma. European Journal of Cancer and Clinical Oncology 25(5): 911-912
Kreuser, E.D.; Hilgenfeld, R.U.; Matthias, M.; Hoksch, B.; Boewer, C.; Oldenkott, B.; Lenk, H.; Wiener, N.; Boese-Landgraf, J.; Schalhorn, A. 1992: A phase Ii trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Seminars in Oncology 19(2 Suppl 4: 57-62
Ilson, D.H.; Motzer, R.J.; Kradin, R.L.; Vogelzang, N.J.; Bajorin, D.F.; Scher, H.I.; Nanus, D.; O'Moore, P.; Marathias, K.; Bosl, G.J. 1992: A phase Ii trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(7): 1124-1130
Mittelman, A.; Puccio, C.; Ahmed, T.; Zeffren, J.; Choudhury, A.; Arlin, Z. 1991: A phase Ii trial of interleukin-2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinoma. Cancer 68(8): 1699-1702
Clark, R.H.; Dimitrov, N.V.; Axelson, J.A.; Charamella, L.J.; Stott, P.B. 1989: A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy. American Journal of Clinical Oncology 12(1): 75-77
O'Brien, M.E.; Bayliss, E.J.; Stewart, M.E.; Smyth, J.F.; Rodger, A.; Leonard, R.C. 1990: A phase Ii trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancer. Cancer ChemoTherapy and Pharmacology 27(1): 79-80
Weiner, S.A.; Aristizabal, S.; Alberts, D.S.; Surwit, E.A.; Deatherage-Deuser, K. 1988: A phase Ii trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecologic Oncology 30(1): 1-6
Saleh, M.N.; LoBuglio, A.F.; Wheeler, R.H.; Rogers, K.J.; Haynes, A.; Lee, J.Y.; Khazaeli, M.B. 1990: A phase Ii trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data. Cancer Immunology Immunotherapy: Cii 32(3): 185-190
Presgrave, P.; Woods, R.; Kefford, R.; Bell, D.; Raghavan, D.; Levi, J. 1988: A phase Ii trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer. Investigational new Drugs 6(3): 219-221
Presgrave, P.; Woods, R.; Dalley, D.; Bell, D.; Levi, J. 1988: A phase Ii trial of oral 4'demethoxydaunorubicin in advanced colorectal carcinoma. American Journal of Clinical Oncology 11(5): 564-565
Kleisbauer, J.P.; Taytard, A.; Balmes, P.; Reynaud-Gaubert, M.; Vergeret, J.; Targhetta, R.; Thomas, P.; Bonnaud, F.; Poirier, R. 1992: A phase Ii trial of pirarubicin in untreated disseminated small cell lung cancer. a cooperative study of the French Pneumo-Cancerology Group. Revue des Maladies Respiratoires 9(2): 179-184
Yoshida, Y.; Hirashima, K.; Asano, S.; Takaku, F. 1991: A phase Ii trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. British Journal of Haematology 78(3): 378-384
Kemeny, N.; Childs, B.; Larchian, W.; Rosado, K.; Kelsen, D. 1990: A phase Ii trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma. Cancer 66(4): 659-663
Taal, B.G.; ten Bokkel Huinink, W.W.; Simonetti, G.; Franklin, H.; McVie, J.G. 1990: A phase Ii trial of sequential MTx and 5-FU alternated with 4-epidoxorubicin and cisplatin in advanced gastric cancer. Cancer Investigation 8(5): 501-504
Engstrom, P.F.; Levin, B.; Moertel, C.G.; Schutt, A. 1990: A phase Ii trial of tamoxifen in hepatocellular carcinoma. Cancer 65(12): 2641-2643
Legha, S.S.; Ring, S.; Papadopoulos, N.; Raber, M.; Benjamin, R.S. 1990: A phase II trial of taxol in metastatic melanoma. Cancer 65(11): 2478-2481